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ABSTRACT 
Feasibility and Optimization of a P300-based Brain Computer Interface in Individuals with 
Amyotrophic Lateral Sclerosis 
Jennifer Giles King 
Dr. Ryszard Lec, PhD and Sara Feldman MA, PT, ATP 
Amyotrophic Lateral Sclerosis is a neuromuscular disease characterized by progressive weakness 
resulting in a state of profound disability including the loss of functional speech. The rise of new 
technologies allows people living with ALS and other individuals with severe motor disabilities 
to communicate using alternate methods. One alternative communication method is an 
Electroencephalographic (EEG) based brain-computer interface (BCI), which uses a cap 
embedded with electrodes to read EEG signals. In particular, the P300, a naïve response to 
stimuli, is used.  Through a P300 Speller paradigm, the EEG-based BCI allows individuals with 
severe disabilities to communicate using a computer even when conventional devices that require 
mechanical manipulation have failed.  
An electrode test system was designed to determine whether the commercial electrode cap was 
functioning correctly.  Direct input from a function generator was provided to 4 electrodes at a 
time and the resulting signal was measured using a DATAQ acquisition box and signal 
acquisition software.  A generated sine was seen in each electrode with a signal loss of 5-6%.  
The electrodes were able to adjust to and reflect changes in input amplitude and frequency, 
demonstrating adequacy in signal acquisition.   
Four able-bodied and eight individuals with ALS from the Philadelphia community participated 
in the P300 Speller trials under informed consent to determine the feasibility of using the BCI in 
an ALS population.  The EEG was recorded with 8 electrodes using an electrode cap.  All aspects 
of data collection were controlled by the BCI2000 system.  Users were asked to participate in a 
copy-spelling session in which they attended to a specified target letter appearing in a letter 
 xii 
matrix.   All controls and 6 out of 8 individuals with ALS were considered to be responders 
(spelling accuracy over 75%).  Spelling ability is not correlated to the ALS Functional Rating 
Scale (ALSFRS), age, or gender.  This indicates that individuals who are extremely disabled are 
able to accurately use a BCI.   
There are differences in the P300 signal between healthy controls and individuals with ALS.  The 
latency of the peak amplitude of the P300 signal is significantly (p=0.020) later in healthy 
controls compared to individuals with ALS.  The peak amplitude of the P300 signal is not 
significantly different in healthy controls compared to individuals with ALS.  In 3 out of 4 
healthy controls, activity can be visualized across all 8 electrodes in the cap whereas in 7 out of 8 
individuals with ALS, activity can be visualized primarily in channels 1-4.  Changes in latency 
and signal movement through the electrodes may indicate differences in the electrical wiring in 
the brain.  However, these changes do not affect the ability of an individual to use the BCI and do 
not influence the amplitude of the signal.   
The ground and reference electrode locations were changed to determine the flexibility of the BCI 
and to optimize electrode placement.  Examined healthy controls and individuals with ALS were 
considered responders at each electrode location.  The ideal location and number of flashing 
sequences varies between individuals, however, the ability to move the electrodes without 
detriment demonstrates that the system can be manipulated to improve comfort and overall 
satisfaction with the BCI.   
BCIs can be used by individuals with a debilitating disease such as ALS to communicate with the 
external world and control their environment.  The BCI system and the P300 Speller paradigm are 
dynamic, flexible, and can be made to work for the majority of individuals with both comfort and 
ease.   
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1. PROBLEM STATEME&T 
Individuals with Amyotrophic Lateral Sclerosis (ALS) and other neuromuscular disorders often 
have trouble communicating through traditional output pathways.  Brain computer interfaces 
(BCIs) allow for an alternative method of communication and have been shown to work well in 
healthy controls.  The BCI should be made feasible for an ALS population.  Additionally, the 
system should ensure user comfort and spelling accuracy through optimization of individual 
system components.  
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2. SPECIFIC AIMS 
1.  Design an electrode test system to ensure efficient detection of brain waves. 
The current BCI2000 software and protocol does not include determination of working 
electrodes before the electrode cap is placed on the subject.  A model system will allow 
testing of the cap to ensure that all electrodes are working properly before the cap is used 
in an experimental or home setting.  The user must be able to continue to wear the cap 
without detriment while this test is performed. 
2.  Determine the feasibility of using the P300 Speller paradigm of a BCI for healthy controls and 
individuals with ALS. 
Healthy controls as well as individuals with ALS will be tested to determine the 
feasibility of using the P300 Speller as a communication device. The P300 signal is 
different in all individuals.  The goal is to determine whether such differences are truly 
individual or whether they may be attributed to other factors such as gender, age, or 
disease progression. 
3.  Optimize the placement of ground and reference electrodes based on spelling accuracy and 
subject comfort.   
The ground and reference electrodes will be placed on (1) the left and right mastoid, (2) 
directly below the left and right ear, and (3) 5 cm below the left and right ear with the 
goal of maximizing subject comfort and system usability.   
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3. BACKGROU&D A&D LITERATURE SURVEY 
3.1 Amyotrophic Lateral Sclerosis 
ALS is characterized by progressive weakness resulting in a state of profound disability including 
the loss of functional speech. As the motor neuron system degenerates, ALS often manifests in 
the form of muscle weakness, muscle atrophy, fasciculations, and multiple combinations of 
corticospinal tract signs [1]. Symptoms are mainly related to muscle control and there is no 
sensory involvement, either electrically or clinically [2]. 
Although ALS is the most common motor neuron disease (MND) among adults [1], it is still 
considered to be a rare disease.  The annual incidence of ALS is 1-2/100,000 people and the 
prevalence is 5/100,000 population with an estimated 20,000-30,000 present cases in the United 
States [2].  The most common age of disease onset is between 55 and 75 years of age, with males 
being 1.5 to 2.0 times more likely to be diagnosed.  The majority of individuals with ALS die 
within five years of diagnosis, but 8-22 percent may survive for a minimum of 10 years [3].   
3.1.1 The ALS Functional Rating Scale 
The ALS Functional Rating Scale (ALSFRS) is a validated questionnaire which measures 
physical function in the daily living of individuals with ALS.  It is often used in clinical trials as 
well as clinical practice due to its ease of use and correlation with disease status and disability 
level.  The ALSFRS is presented as a score out of 48, where 48 indicates normal daily living 
habits and 0 indicates complete dependency [4].  The full questionnaire is presented in Appendix 
A. 
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3.1.2 Treatment of Symptoms in ALS 
Much of the treatment surrounding ALS involves symptom management and supportive 
therapies.  Speech Language Pathologists are used early in the disease process to teach 
individuals with ALS and their families how to communicate with minimal effort through 
nonverbal modalities [3].  An assistive technology professional helps individuals with 
communication issues to explore the myriad of technological communication devices.  The rise of 
new technologies, including BCIs, allows people living with ALS and other individuals with 
severe motor disabilities to communicate using alternate methods even after other conventional 
devices have failed.   
3.2 Brain Computer Interfaces 
There are nearly two million people in the world affected with disorders such as ALS in which 
the neuromuscular channels that the brain uses to communicate with and control the external 
environment are disrupted. Those individuals which are most affected risk losing all voluntary 
muscle control, including respiration and eye movement.  Modern life-support technology can be 
used to prolong life, yet doing so also prolongs the personal, social, and economic burdens of the 
disability [5]. 
3.2.1 Options for Enabling Function for Individuals with Disabling Disorders 
There are three main options for enabling function once it has been lost due to a disorder.  The 
first option is to compensate for the loss by using alternate methods to perform the same action.  
Muscles which perform under voluntary control can be used as substitutes for paralyzed muscles.  
For example, eye movements may be used to answer questions, give commands, or operate a 
computer program to synthesize speech.  The second option is to proceed around breaks in the 
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neural pathways which control muscles, such as using electromyographic (EMG) activity from 
muscles above a lesion to control stimulation of paralyzed muscles and restore movement [5]. 
The third option for individuals with motor impairments is to provide the brain with a non-
muscular channel for communication and control.  A direct brain-computer interface (BCI) can be 
used to convey messages and commands from the brain to the external world.  A variety of 
methods, including Electroencephalography (EEG), positron emission tomography (PET), 
functional magnetic resonance imaging (fMRI), and optical imaging, may be used to perform 
such a task.   
3.2.2 Definition of a Brain Computer Interface 
A BCI is generally defined as a communication system in which messages or commands that an 
individual sends to the external world do not pass through the normal output pathways of 
peripheral nerves and muscles.  A BCI is considered dependent if it does not use the brain’s 
normal output pathways to carry the message but the activity in these pathways is necessary for 
the generation of brain activity which does carry the output.  Although a dependent BCI does not 
provide the brain with a new communication channel, it is still useful.  An independent BCI does 
not depend on the brain’s normal output pathways in any way.  The message is not carried by 
peripheral nerves and muscles and activities in these pathways are not needed to create brain 
activity which does carry the message.  For individuals who lack all normal output channels, 
independent BCIs are likely to be the most useful, as they only require signal generation 
dependent on the intent of the user [5].   
A BCI accomplishes the user’s intent as would the output in conventional neuromuscular 
channels.  It replaces the nerves and muscles with electrophysiological signals and the 
movements they produce with hardware and software that translates the signals into action.  Since 
the brain’s normal output channels rely on feedback, a successful BCI must provide feedback and 
interact with any adaptations the brain may ma
performance depends on interaction between the brain producing the signals measured by the BCI 
and the actual BCI that translates the signals to commands 
3.2.3 The Parts of a Brain Computer Interface
 A BCI, like any communication system, requires input from the user, an output, elements which 
translate the input into output, and a protocol which defines the onset, offset, and timing of 
operation [5].  The interactions of these elements are shown in 
Figure 1:  Schematic of the design and operation of a BCI system.  Signals from the brain are acquired 
through electrodes and processed for 
are then translated into commands which can operate a device.  The user must develop and maintain good 
correlation between intent and the signal features extracted so that device comm
efficient (adapted from [5]).  
 
 
ke in response to the feedback.  Thus, BCI 
[5].  
 
Figure 1. 
signal extractions which reflect the intent of the user.  These features 
ands are correct and 
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3.2.3.1 Signal Acquisition 
In the signal-acquisition phase of operation, the chosen input is acquired through the recording 
electrodes.  For example, evoked inputs, such as EEG produced by flashing letters, result from 
stereotyped sensory stimulation.  The signal is consequently amplified and digitized [5].   
3.2.3.2 Signal Processing 
Once the signals are digitized they are subjected to feature extraction procedures such as spatial 
filtering, voltage amplitude measurements, spectral analyses, and single-neuron separation.  The 
goal is to extract the signal that encodes the user’s commands.  BCIs may use features in either 
the time or frequency domain and the use of both may enhance performance.  Signal features 
used to control BCIs today reflect identifiable brain events.  The knowledge of the location, size, 
and function of a particular rhythm or evoked potential dictates how the potential should be 
recorded and how users may learn to control the potential.  A BCI may use signal features which 
correlate with the user’s intent but do not correlate with specific brain events.  However, 
additional efforts must be made to ensure that these signals are not contaminated with non-central 
nervous system artifacts, such as EMG or electrooculography (EOG) [5].   
The first stage of signal processing extracts the specific features of the signal.  The next stage is 
the translation algorithm which translates these features into commands to carry out the intent of 
the user.  Both linear and nonlinear methods may be used to change the signal features into 
control commands.   
The most effective algorithms are those which adapt to the user.  When a new user operates the 
BCI, the algorithm adapts to the individual user’s signal features.  For example, the algorithm 
adjusts to the characteristic P300 amplitude of the user.  This first level of adaptation will only 
remain effective if the user’s performance is stable.  However, variations linked to time of day, 
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hormones, environment, fatigue, and illness may all cause changes in the signal.  Therefore, 
periodic adjustments are necessary to reduce the impact of spontaneous variation.  Ideally, the 
user’s range of feature values will span the available range of command values even over an 
extended period of time [5].   
These levels of adaptation do not take the interaction of the BCI and the brain of the user into 
account.  Thus, the final level of adaptation works with the adaptive abilities of the brain.  The 
brain will modify signal features in order to improve the operation of the BCI.  Development of 
such skills may be rewarded with faster communication abilities in both controls and individuals 
with muscle diseases [5].  
3.2.3.3 The Output Device 
Selection of a target can be indicated in a variety of ways including visual and auditory stimuli.  
Although the actual output of a BCI system is target selection, the output device for current BCIs 
is a computer.  Through a computer output, BCIs can provide cursor movement, communication 
programs, and prosthesis control [5]. 
3.2.3.4 The Operating Protocol 
A standard protocol guides the operation of each BCI system.  It determines how the system is 
powered on and off, the continuity of communication, the method of message transmission, the 
sequence and speed of interactions with the user, and the type of feedback provided.  
Unfortunately, most laboratory BCI systems do not provide the user with on/off or message 
control [5].  In order to be fully moved out of the laboratory and into the home, protocol 
adjustments will need to be made so that the user is able to control and use the device 
independently.   
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3.2.4 Brain Wave Measurement Techniques 
EEG, PET, fMRI, and optical imaging are all control options for BCIs.  However, MEG, PET, 
fMRI, and optical imaging remain technically demanding as well as expensive.  In addition, PET, 
fMRI, and optical imagining rely on blood flow, have long time constants, and are less amendable 
to rapid communication.  Only EEG offers the possibility of a practical BCI, as it has a relatively 
short time constant, can function in the majority of environments, and requires relatively simple 
and inexpensive equipment [5].   
Although the EEG reflects brain activity, the resolution and reliability of the detectable 
information is limited by the great number of electrically active neuronal elements, the electrical 
and spatial geometry of the brain and head, and the variability in trials of brain function.  
However, scientific studies have shown that the relationships between evoked potentials, their 
mechanisms of origin, and their relationships with brain function are no longer unknown.  In 
addition, EEG-based communication requires the ability to analyze the EEG in real time. The 
rapid development of inexpensive computer hardware and software allows for online analyses of 
a multichannel EEG [5].  The advancements of science and technology have placed scalp-
electrode EEG communication in a practical realm.   
3.3 The Source of the Electroencephalography Signal [6] 
EEG is the difference in voltage between two different electrode locations over a period of time.  
One electrode is placed on the scalp and at least one additional electrode is placed elsewhere on 
the body to ensure a voltage difference can be determined.   
EEG is produced mainly by cortical postsynaptic potential changes which alter the electrical 
charge present across the pyramidal cell membrane.  These cortical neurons have a membrane 
potential equal to the difference between the interior cell potential and the extracellular space.  
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This resting potential changes as a result of extraneous impulses arriving from other neurons on 
the cell body.  These impulses cause electrical current flow along the cell body membranes and 
dendrites.  Such changes can reduce the membrane potential to generate an action potential which 
may be propagated along the axon.  The changing EEG signal is a temporal and spatial 
summation of thousands of inhibitory and excitatory postsynaptic potentials of the pyramidal 
cells.   
In addition to these postsynaptic potentials there are also intrinsic cellular currents that are 
mediated by ionic channels producing extracellular potentials with high amplitude and long 
duration.  Most likely, these extracellular potentials also contribute to the signal seen on the EEG 
monitor.  Intrinsic currents are present in neocortical cells which produce a discharge of a cluster 
of action potentials.  This firing in combination with an afterhyperpolarization potential creates an 
event lasting longer than a general synaptic potential.  In addition, this burst firing tends to occur 
with other neurons in the cell population.  These characteristics are important for creating 
potentials which may be recorded at the level of the scalp.  Single action potentials contribute 
very little or nothing to the recorded EEG. 
3.3.1 The Resting Potential of the &euron 
The resting potential of a neuron generally lies between -40 and -80 millivolts (mV) with an 
average value of -65 mV and is negative on the inside of the cell membrane with respect to the 
extracellular region.  The passive properties of this potential do not require metabolic energy and 
result from impermeability of the membrane to sodium, potassium, chloride and other ions.  
Diffusion, along with electrical gradients, helps to drive ions out of the cell for even distribution 
across the membrane.  Active properties of the membrane need metabolic energy to counteract 
ion leakage across the membrane.  The most important active transport is the sodium-potassium 
pump, which is responsible for transporting sodium out of the cell and bringing potassium into 
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the cell.  Conditions that disrupt metabolism within the brain may reduce the action of this pump, 
thus reducing the membrane potential and increasing excitability within the neuron. 
3.3.2 Postsynaptic Potentials in &erve Cells 
Postsynaptic potentials are due to action potentials from other neurons arriving at a nerve cell 
through an axon.  The impulse in the afferent neuron causes the release of a neurotransmitter 
substance which diffuses across the synaptic cleft to interact with a specialized receptor.  The 
interaction creates a change in membrane permeability to certain ions and there is a local change 
in membrane resting potential.   
An excitatory postsynaptic potential (EPSP) is a partial reduction in membrane potential.  It is 
transient and most often due to increased permeability of the membrane to sodium and potassium 
ions.  The entry of sodium into the cell results in partial depolarization.  On the other hand, an 
inhibitory postsynaptic potential (IPSP) is caused by the entry of chloride ions into the cell and 
increases negativity.  Even though the cell is relatively negative inside, a high extracellular 
chloride concentration causes an influx of ions.  IPSPs generated at different areas of the cell 
likely sum to hyperpolarize the cell.  The neuronal membrane potential is altered by several mV 
and may last over 100 milliseconds (ms) as electrical current flows change the membrane 
potential in the cell body. 
3.3.3 Action Potentials 
Action potentials arise when the neuronal membrane becomes depolarized above a particular 
threshold value.  The threshold is lowest at the axon hillock, where most depolarization occurs.  If 
the membrane becomes depolarized by at least 10 mV a sequence of events ensues.  There is a 
brief increase in membrane permeability to sodium and potassium ions leading to a quick reversal 
in membrane potential and subsequent repolarization.  The electrical change lasts for about 1 ms 
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and is approximately 100 mV.  This action potential does not penetrate deeply into extracellular 
space, but a wave of excitation follows throughout the cell membrane to cause an EPSP or IPSP 
to occur in other neurons.   
3.3.4 Summation of Electrical Potentials in the Cortex 
The summation of electrical potentials mainly occurs in vertically oriented large pyramidal cells 
for specific reasons.  The dendrites of the pyramidal cells extend throughout the majority of the 
layers of the cortex, allowing a guide to current flow developed in both deep and superficial 
layers.  The cells are arranged in parallel in vertical columns to facilitate spatial summation.  
Groups of neurons receive similar inputs and respond with changes in potential that are similar in 
direction and timing.  Only one afferent axon is needed to contact several thousand cortical 
pyramidal neurons.  Finally, each pyramidal cell maintains over 100,000 synapses, allowing input 
to the cells to be magnified. 
The currents created by pyramidal cells are summed in the extracellular space.  Although the 
majority of the current is limited to the cortex, a small amount is able to penetrate to the scalp.  
Different currents cause different areas of the scalp to be at different potential levels.  Even 
though these differences are usually only between 10 and 100 µV, they can be recorded through 
two electrodes and define the EEG. 
EEG is the result of individual neuronal potential changes.  However, micro electrode activity 
from individual cells does not correlate well with EEG activity due to the large numbers of 
potentials summed to generate the ongoing EEG.  In addition, it is not possible to know whether 
the EEG event recorded at the scalp is a consequence of an IPSP or EPSP.  Although EPSPs and 
IPSPs produce opposite directions of current flow, if they are located at opposing ends of the 
vertical pyramidal cell the current seen by a surface electrode will appear to have the same 
polarity.   
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3.4 Using Scalp Electrodes to Record the Electrical Potentials [6] 
Electrodes on the scalp will mainly record those potentials summed in the cortex.  They may, in 
rare cases, record potentials generated in distant parts of the brain.  Electrodes may also record 
artifacts, or signals produced outside of the brain.  The intensity of the electrical source, its 
distance from the recording electrode, and its spatial orientation along with the electrical 
resistance and capacitance between the source and the electrode all determine the amplitude of 
the recorded potential.  Therefore, it is important for the potential to occur near the recording 
electrode; be generated by cortical dipole layers oriented towards the recording electrode at 90 
degrees to the scalp surface; be generated in a large tissue area; and rise and fall at a rapid speed.   
EEG recorded with scalp electrodes differs from one recorded with electrodes placed on the 
cortex.  Scalp EEG is lower in amplitude and may be distorted in shape.  Higher frequencies are 
generally attenuated more than lower ones and very fast or brief potential changes may not be 
seen in scalp recordings.  Scalp EEG amplitude may decrease as a result of the increase in 
electrical impedance between the source and recording electrodes (such as a thick skull which 
would reduce current flow) or a decrease in the impedance at different stages in the path of the 
current before it reaches the recording electrode.  However, scalp EEG is preferable in a disabled 
population due to complications seen in surgical placement of electrodes on the cortex.   
3.4.1 Scalp Electrode Placement 
The International 10-20 system provides uniform coverage of the scalp [7].  Distances between 
bony parts of the head (the inion, nasion, and preauricular point) are used to create a system of 
lines that run across the head.  These lines intersect at intervals of 10 or intervals of 20% of their 
total length and electrodes are placed at these intersections.  Recording electrodes are identified 
with an abbreviation indicating the underlying region:  prefrontal (Fp), frontal (F), central (C), 
parietal (P), occipital (O), and auricular (A).  The letter z indicates midline sagittal placement, 
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odd numbers indicate lateral placement on the left, and even number indicate lateral placement on 
the right.  Numbers increase with increasing distance from the anterior posterior midline of the 
head.   
3.4.2 Electrode Placement for the P300 
The electrode placement for obtaining one specific wave, the P300, is a modified version of the 
International 10-20 system which uses only 8 electrodes.  The electrodes are placed in locations 
(1) Fz, (2) Cz, (3) P3, (4) Pz, (5) P4, (6) PO7, (7) Oz, and (8) PO8. These positions are highlighted in 
blue as shown in Figure 2.  Further explanation of the P300 is given in Section 3.8. 
 
Figure 2:  Modified International 10-20 system used for electrode placement when obtaining an EEG in 
preparation for use of the P300.  
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3.4.3 Metal Disc Electrodes for Scalp EEG 
Metal disc or cup electrodes generally have a diameter between 4 and 10 millimeters (mm).  
Smaller or larger electrodes result in unstable mechanical and electrical contact with the scalp.  
Discs should be made of a material which does not interfere with scalp electrolytes, such as gold, 
silver chloride, tin, or platinum.   Insulated wire is attached to each electrode for easy 
identification of wires and corresponding electrodes.  If the wires are attached to one another in 
the form of a stranded cable, mechanical and electrical problems may be reduced.   
Alternative current impedance should lie between 100 and 5000 ohms in diagnostic testing and 
should be measured before every EEG recording session.  Extremely low impedance is not 
desirable because it acts as a shunt and effectively short circuits the potential differences in EEG.  
High impedance is not desirable because connecting an electrode of low impedance to one of 
high impedance creates an imbalance that favors the recording of interference at 60 Hz.   
By the time the signal reaches the electrode on the scalp, it has been modified significantly 
through three main avenues.  First, there are multiple tissues which lie between the signal 
generation in the cortex and the recording electrodes.  Each tissue has unique electrical 
conductive properties which will alter the signal.  Second, the signal may not be directed at the 
recording electrodes.  Thus, the orientation may not be direct.  Finally, the recording electrode 
and the scalp-electrode interface have unique conductive properties which may alter the signal.  
Examples of this include the size of the electrodes, the electrical properties of the materials used, 
and the impedance resulting at the electrode-scalp junction.   
3.5 Parts and Functions of a Digital EEG Instrument [6] 
A digital EEG system is simply analog EEG combined with an analog to digital converter to 
display EEG on a personal computer.  Although digital EEG lacks visual clarity of the waveform 
 16 
there are many useful tools for analysis include montage, filter, and gain selection.  Storage space 
and record retrieval time are also reduced. 
3.5.1 Digital Calibration 
Calibration for digital EEG instruments can be performed through the use of an external signal 
generator.  A sine wave with a frequency ranging between 0 and 70 Hz should be used.  Refer to 
Section 5 for the design of an electrode test system that may be used while the individual is 
wearing an electrode cap. 
3.5.2 EEG Amplifiers 
EEG amplifiers are used to perform differential discrimination as well as amplification.  
Discrimination refers to the ability of the amplifier to determine a difference in electrical potential 
between two electrodes while using common mode rejection.  Thus, only the difference between 
the incoming signals to the electrodes is amplified.  This differential discrimination allows the 
amplifier to remove electrical noise from the signal and eliminate electrical potentials which are 
not from the brain.  Single ended amplifiers do not subtract inputs from one another and instead 
compare the difference between a single electrical input and an electrical ground.   
Impedance is a main concern in signal amplification.  Unequal impedance in recording electrodes 
at two input locations causes electrical potentials with the same amplitude to appear with different 
amplitudes on the recording.  This difference will then be enlarged.  The most common cause of 
an imbalance is loss of contact between the electrode and the scalp. In this case, only the 
difference between a single electrode and the ground is being displayed.  Artifacts also play a 
role, as discussed in section 3.6. 
The amplification step increases the difference in voltage between signal inputs.  The biological 
signal may be increased from millivolts to volts and can be characterized in terms of both 
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sensitivity and gain.  The sensitivity (µV/mm) is defined as the ratio between input voltage and 
the produced signal deflection. A common value is 7 µV/mm but sensitivity of each channel can 
be adjusted between 1 µV/mm and 1000 µV/mm.  A higher value indicates a lower amplification 
recording and will make a calibration signal appear smaller.  Sensitivity can be measured directly 
and, therefore, is more often used to describe amplification than gain. 
Gain is defined as the ratio of signal voltage at the amplifier output to the applied signal voltage 
at the input.  Standard EEG has a maximum gain of 1 million.  Unlike sensitivity, gain is defined 
such that increases in gain correspond with increasing amplification.  Because gain cannot be 
measured directly it is not useful in a clinical setting.   
3.5.3 EEG Filters 
Filters can used to exclude certain waveforms and record only those frequencies which are in the 
most important range (1-30 Hz).  Filters receive the input signal after it has been passed through 
the differential amplifier to a single-ended amplifier.  Once the signal passes through the filter, 
the signal is again amplified by single-ended amplifiers.  A low frequency filter (Figure 3a), also 
known as a high pass filter, reduces the amplitude of slow waves and allows higher frequencies to 
pass through the amplifier without attenuation.  A high frequency filter (Figure 3b), also known 
as a low pass filter, reduces the amplitude of fast waves and allows lower frequencies to remain 
while attenuating higher frequencies.  High frequency filters must include frequencies faster than 
those considered important in EEG so that muscle activity may be filtered.  A notch filter reduces 
the amplitude of waves in a particular frequency range to remove interference from electrical 
lines.  In North America, this is set at 60 Hz to filter interference from devices powered by 
alternating current.   
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a      b  
Figure 3:  Equivalent electrical circuits for (a) a low frequency filter and (b) a high frequency filter. 
Filters distort the time relation between waves of frequencies located close to cutoff frequencies.  
A phase shift, or phase distortion, occurs as the filters delay or advance these waves in varying 
time amounts.  A low frequency filter advances the peak of a slow waveform whereas a high 
frequency filter delays the initial deflection of a faster waveform.  Such shifts become important 
in analyzing events which occur in the millisecond range, such as evoked potentials.   
3.6 EEG Artifacts [6] 
One issue with EEG recordings is the presence of artifacts.  Artifacts are potentials seen in EEG 
that do not originate in the brain.  While they may sometimes be recognized by their shape and 
distribution, they often go unnoticed during the recording session.  It is important to realize that 
potentials which are medium to high amplitude and occur only at a single electrode are normally 
artifacts.  Potentials generated in the cortex demonstrate a distribution across the scalp with a 
characteristic maximum that gradually drops in voltage with increasing distance.  Simultaneous 
waveforms that are repetitive or irregular and occur in unrelated regions of the head are also 
usually artifacts.  Potentials usually evolve across electrodes and do not jump between locations 
on opposing sides of the brain. 
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3.6.1 Artifacts from the Patient 
Blinking and other eye movements cause changes which are mainly seen in frontal electrodes.  
However, these potentials may extend into the central or temporal electrodes.  Rapid eye 
movements will result in jagged artifacts.  Traditionally, eye movement artifacts were thought to 
be due to the movement of the eyeball, as the cornea is about 100 mV positive compared to the 
retina.  However, the movement of this dipole is not needed to produce a blink and simple 
movements of the lid across the eyeball may result in similar artifacts.  In general, it is assumed 
that activity in the alpha frequency range which is localized to the frontopolar head regions is due 
to eye movement artifacts.  If it becomes difficult to distinguish eye movement from cerebral 
activity, electrodes may be placed near the eyes and linked to record eye movement.   
Muscle activity causes short duration potentials which often occur in either clusters or periodic 
runs.  The spikes may occur as discrete potentials and resemble cerebral spikes or they may occur 
in rapid bursts and cover the cerebral spikes.  Artifacts arising from the scalp and facial muscles 
are seen mostly in the frontal and temporal electrode recordings.  Muscle artifacts can be 
identified through shape and repetition and can often be reduced or eliminated by requesting that 
the subject relax, open their mouth, or change position.  Some individual electrodes may need to 
be repositioned.  Special EEG patterns are seen in repetitive movements like chewing, blinking, 
or tremors.  Any monorythmic pattern that appears isolated from other background activity 
should be examined as a possible source of a muscle artifact. 
Movements of the head, body, or electrode wires may also cause artifacts.  These artifacts are 
rhythmical and are caused by the force of the blood rushing to the head.  They can be recognized 
by their association with actual movements and can often be eliminated by asking the subject to 
remain still during recording.   
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Charges generated in the heart may be picked up in EEG recordings if electrodes are spaced far 
apart, such as linkages between opposite sides of the head.  Such artifacts may appear in all 
channels if a common reference is used or may only appear in select channels.  Smaller artifacts 
are indicative of the R wave of the electrocardiogram (ECG) whereas larger artifacts may reflect 
other components.  If ECG artifacts are extremely large, they are likely due to the presence of a 
cardiac pacemaker.  Unlike other artifacts, ECG artifacts cannot usually be eliminated and may 
not be reduced by changing or moving electrodes.   
There are two artifacts produced by the skin.  The perspiration artifact appears in more than one 
channel as slow waveforms which are generally longer than 2 seconds in duration.  Perspiration 
causes shifts of the electrical baseline by changing either the impedance of the electrode or the 
contact between the electrode and the skin.  The perspiration artifact can be reduced by cooling 
the subject and ensuring the scalp is dry through the use of a fan or alcohol.   
The second artifact produced by the skin is the sympathetic skin response.  It consists of slow 
wave with duration of 0.5-1 second.  This represents an automatic response that is created by 
sweat glands and skin potentials in response to a sensory stimulus or psychic event.  It is more 
likely to appear as the external temperature increases.   
3.6.2 Artifacts from Electrodes and Other Equipment 
Artifacts which come from the electrodes and associated wires often appear superimposed on the 
overall EEG signal and only in one channel.  A sudden change in electrical contact will often 
cause a sharp fall or rise in the EEG.  To identify and correct these artifacts, the electrode in 
question must be checked for electrical and mechanical continuity.  The discontinuity may be the 
result of a broken connection, lack of conductive gel, or faulty wiring.   
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The most common artifact has a frequency of 60 Hz and is due to electrical interference arising 
from power lines and equipment.  Some amount of this interference is unavoidable in any setting 
where alternating current is used and it is likely to appear in all channels.  It is introduced either 
electrostatically though unshielded power cables or electromagnetically by cables carrying strong 
current.  Other sources of interference include televisions, radios, ringing telephones, people 
walking through the room, or the use of an intravenous drip.  Since modern EEG machines have 
high discrimination, all external sources of interference are often rejected.   
3.6.3 Artifacts of Concern in Individual with ALS 
Many individuals with ALS, especially those further in disease progression, maintain little muscle 
movement or control.  Therefore, muscle and movement artifacts are not of great concern.  
However, these individuals also often retain the need for external life support and intravenous 
treatments during system use.  Ventilators, cough assist machines, and monitoring devices all 
contribute environmental interference.  In addition, trials with this population are often run in a 
hospital or home environment.  There is frequently extra equipment in the room and health 
professionals, family members or caregivers passing though the testing area.  Since these sources 
of artifacts and interference cannot be eliminated, one goal of the BCI project is to make the 
system accurate in the presence of these artifacts such that it may be used in a home or hospital 
environment as a communication device.   
3.7 Types of EEG Brain Computer Interfaces 
Current BCI systems fall into 5 categories based on the electrophysiological signals used for 
system control.  The first category uses visual evoked potentials [5] which depend on muscular 
control of gaze direction.  Because many individuals with advanced ALS lose their ability to 
control eye movement, this is not an adequate choice for the population.   
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Mu and beta rhythms (Figure 4a) and slow cortical potentials (Figure 4b) require training for BCI 
use.  Mu and beta rhythms are associated with the brain’s normal motor output channels [5].  
Because such channels may be disrupted in individuals with ALS, this is also not an appropriate 
choice.   
 
Figure 4:  Possible implementations of the BCI.  (a) Mu and beta rhythm control of cursor movement.  Left:  
Topographical distribution on the scalp, Center:  Voltage spectra for a location, and Right:  Corresponding 
r
2
 spectrum for top versus bottom targets.  (b) Slow cortical potential control of cursor movement.  Left:  
Topographical distribution on the scalp, Center:  Time course for the EEG, and Right:  Corresponding r
2
 
time course.  (c) P300 control of a spelling program.  Left:  Topographical distribution on the scalp, Center:  
Time course for the EEG, and Right:  Corresponding r
2
 time course [8]. 
The P300 wave (Figure 4c) requires no initial user training and is a normal response to the 
presentation of infrequent stimuli.  Use of the P300 evoked potential for BCI use has been 
successful in ALS populations [9-13].  Therefore, this discussion will focus on systems which use 
the P300 evoked potential for communication. 
 
a 
b 
c 
 23 
3.8 Characteristics of the P300 Wave 
The P300 is a robust wave presented in individuals at all ages.  It is a typical or naïve response to 
a desired stimulus.  Although the P300 may change or habituate over time, because it requires no 
initial training, additional translation algorithms may be implemented to maintain a response [5].   
3.8.1 P300 Theory 
The “oddball” paradigm is often used to elicit the P300.  In a single-stimulus trial the target is 
presented infrequently with no other stimuli.  In a two-stimulus trial, an infrequent target is 
presented in the background of frequent standard stimuli.  This is the most common method of 
stimulation and is known as the oddball paradigm.  In a three-stimulus trial, an infrequent target is 
presented in the background of frequent standard stimuli and infrequent distracter stimuli [14].  
These differences are illustrated in Figure 5.   
 
Figure 5:  Schematic of the single-stimulus (top), oddball (middle) and three-stimulus (bottom) paradigms 
[14]. 
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The subject must respond to the stimuli either mentally or physically and must make an effort to 
respond only to the target stimuli.  The target stimuli elicit a potential which increases in 
amplitude from the frontal to parietal electrodes [14].   
The P300 amplitude indexes brain actions when a mental representation of the stimulus 
environment is updated [15].  This idea stems from a model of orienting response which was 
derived from the effects of habituation and dishabituation that have been shown to also affect the 
P300 [14].  After initial sensory processing, the current stimulus entering the brain is compared to 
the previous oddball stimulus stored in working memory.  If there is a change detected in the 
stimulus attribute, the old stimulus schema is kept and sensory evoked potentials are recorded.  
However, if a new stimulus is processed, attention mechanisms engage to update the schema.  
This update of representation within the memory may elicit the P300 [16].   
A positive waveform with a maximum amplitude distribution at the central or parietal electrode 
with relatively short peak latency is called the “P3a”.  A “novelty P300” is elicited when a subject 
is presented with non-repeated distracter stimuli such as a dog bark and is associated with 
redirection of attention monitoring.  The novelty P300 is characterized by a maximum amplitude 
distribution at the frontal and central electrodes, short peak latency, and relatively rapid 
habituation.  Recent studies have shown that the P3a and novelty P300 are in fact the same 
potential as distinctions between the two cannot be supported [14]. 
P300 scalp tomography appears to be determined by differences in stimulus and task conditions.  
Outcomes appear in a fashion which suggests the engagement of overlapping neural activations 
with a functional distinction between the P3a (seen initially in the frontal and central electrodes) 
and the emergence of the P3b (seen in the parietal electrode).  As shown in Figure 6, initial 
processing of a stimulus requires early focal attention which determines P3a production.  
Therefore, frontal lobe engagement is necessary for P3a generation and attention control.  
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Initiation of frontal lobe activity engages the attention focus which is demanded by task 
performance.  Later memory comparison determines P3b production.  The stimulus event does 
not need to be perceptually novel to generate a signal [14]. 
 
Figure 6:  Schematic of cognitive events associated with P300.  The P3a is elicited if the stimulus demands 
focal attention.  Working memory engages storage operations to produce a P3b if the subject discriminates 
the target from other presented stimuli [14].    
The neuroelectric events which determine P300 generation arise from the interaction between the 
frontal lobe and hippocampal/temporal-parietal function.  fMRI studies which examine oddball 
tasks obtain patterns consistent with a frontal-to-temporal and parietal lobe activation pattern.  
Once the incoming stimulus goes through frontal processing, activity propagates between the 
cerebral hemispheres and across the corpus callosum [14] to produce the overall waveform of 
P300 shown in Figure 7. 
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Figure 7:  P300 BCI.  Only the choice desired by the user evokes a large P300 potential.  This is the 
positive potential which occurs approximately 300 ms after stimulus presentation [5]. 
3.8.2 Characteristics of the P300 
Stimuli of clicks or brief light flashes evoke a characteristic response among individuals when 
presented at an intensity which is above threshold yet still comfortable.  In original experiments 
presented by Sutton et al., subjects were given two paired stimuli in which each pair had a cueing 
stimulus and a test stimulus.  In the first kind of pairing, the cueing stimulus was followed by a 
test stimulus which was always a sound or always a light, allowing the subject to be certain of the 
sensory quality of the test stimulus.  In the second kind of pairing, the cueing stimulus was 
followed by a test stimulus which was either a sound or a light, such that the subject was 
uncertain of the sensory quality of the stimulus.  The waveforms obtained from EEG recordings 
differ between individuals and stimuli.  However, in 36 out of 36 experiments, there is a large 
positive deflection with peak amplitude at approximately 300 ms [17].  This deflection has been 
termed the P300 component of the event-related brain potential.   
The degree of uncertainty can also be manipulated as shown in Figure 8.  Cueing pairs were once 
again presented, however, in one kind of pair a cue was followed 33% of the time by sound and 
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66% of the time by light whereas in the second kind of pair the inverse was true.  The curves 
represent the average response for one subject.  The top graph shows the effect of sound 
probabilities on the evoked potentials and the bottom shows the effect of light probabilities on the 
evoked potentials.  Each waveform shows the expected deflection at 300 ms, yet the amplitude is 
greatest for a lower probability stimulus [17].   
 
Figure 8:  Average waveforms for different probabilities of light and sound with different cueing stimuli 
[17]. 
The P300 is operationally defined as a component having a latency longer than 275 ms, positive 
in polarity at all midline electrodes, having a maximum positive value at parietal and central 
locations, elicited by stimuli which are task relevant and having an amplitude which is affected by 
both subjective probability and the task relevance of the stimulus [18].  Operational guidelines 
recommended by Fabiani et al. detail that the P300 may be identified on the basis of (a) positive 
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polarity, (b) latency, (c) morphology (a peak must be identifiable), (d) scalp distribution (in 
general, Pz and Cz > Fz and Pz usually > Cz) and, if possible, (e) established relationships with 
probability and target effects [19].   
P300 scalp distribution is defined as the amplitude change over midline electrodes (Fz, Cz, and 
Pz according to the International 10-20 system) and typically increases in magnitude from the 
frontal to parietal electrode locations [20].  The amplitude of the P300 is the difference between 
the lowest negative point prior to the P300 window (baseline voltage) and the highest positive 
point within the P300 window [21].  Latency is defined as the time from stimulus onset to the 
time of maximum positive amplitude within the P300 window [20].  The window is defined as 
the time range where the average wave form is positive and generally ranges between 220 and 
500 ms [21].   
To be fully operational, the definition of the P300 must be more than simply reliable.  A true 
definition of the P300 waveform should satisfy three main criteria:  (a) feasibility (the definition 
should be applicable to real data), (b) reliability (if data is obtained under the same condition for 
the same subject it should reproduce the same results), and (c) validity (the definition should 
correspond to all characteristics of the P300) [19].  In most cases, reliability is the easiest of the 
three characteristics to measure accurately and can be examined within a subject for a single 
session or across multiple sessions by examining the amplitude and latency of the P300.   
The amplitude of the P300 varies inversely with the probability of the stimuli and directly with 
the relevance of eliciting events [21].  Events that require either a response or additional 
processing elicit larger P300 amplitudes [19].  The subject’s ability to accurately discriminate 
events and place them in appropriate categories is crucial.  It is not necessary, however, to report 
occurrence of a target event through direct communication [21].  P300 signals are present as long 
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as the subject is able to remain focused on target occurrence and do not require motor or verbal 
acknowledgement.    
Variations in the scalp distribution of the P300 may be related to differential activity of 
overlapping components or variations in cell populations devoted to the generation of the 
waveform.  The P300 may not arise from a single generator but instead from multiple sources 
with a variety of orientations [22].  Several neural generators may be needed to carry out what is 
seen as a single psychological process.  The same set of sources may be differentially activated to 
accommodate the processing changes required by a particular task.  This then may lead to slight 
changes in scalp topography and provide an explanation for the differences seen among 
individual subjects [19].   
Individual differences seen in the P300 latency are correlated to speed of mental function and 
shorter latencies are related to superior cognitive ability.  P300 latency decreases during 
childhood development and increases with normal aging.  Latency also increases as dementia 
increases [20].  Since individuals with ALS do not tend to have dementia and are within a similar 
age range, an average profile can be determined. 
Stimulus information content, sequence probability structure and the relevance or difficulty of the 
task are all cognitive factors which affect P300.  P300 is sensitive to general and specific arousal 
effects which contribute to information processing and attention activation.  Slow fluctuations in 
energetic arousal state may affect P300 and can be controlled to reduce individual variation [14].   
3.8.3 General Guidelines for the Use of P300 in Published Studies 
To account for the differences and possible problems discussed above, general guidelines have 
been created for the use of P300 waveforms in published studies [19]:   
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1.  Electrodes:  Electrodes should be placed at the electrooculographic (EOG), Fz, Cz, 
and Pz as a minimum for P300. 
2.  Ocular artifacts:  Possible contamination from eye movements should be of a concern 
to investigators and measures to deal with this problem should be considered
1
.   
3.  Recording epoch:  The P300 may be followed by a slow wave which lasts for 
hundreds of milliseconds.  Therefore, the recording epoch should extend at least one 
second from stimulus onset. 
4.  Raw records:  Due to the use of few subjects, all superaverages and typical waveforms 
of single subjects should be presented.  In addition, at least for some averages, 
waveforms for each electrode should be presented.   
5.  Polarity:  Polarity convention (as indicated by the ‘+’ and ‘-‘ sign) should be reported 
in all figures as well as in text or legends
2
. 
6.  Amplitude measurement:  The methods used to determine the peak amplitude of ERP 
components must be specified.  It is also desirable to use more than one method. 
7.  Experimental reports:  Independent variables should be identified and described.  
Atypical subjects should not be eliminated without justification.  An unusual morphology 
is not a reason for rejection, unless such morphology results from artifacts which cannot 
be removed. 
                                                     
1
 Ocular potentials are known to propagate to scalp electrodes.  The EOG electrodes can be used to correct 
event-related activity in both channels.  However, this is not as important for these trials as for locked-in 
individuals eye movement is not a factor. 
2
 Since the publication of these guidelines, it has become standard practice to report the negative deflection 
of the P300 as a positive deflection when the waveform is presented graphically. 
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8.  Debriefing:  All subjects must be debriefed after any experiment.  The equipment 
should be functioning properly, given instructions must be fully understood, and 
information of the subject’s strategies, motivation, and general attitudes toward the 
experiment should be obtained.   
3.8.4 Specific Guidelines for the Use of P300 in Published Studies 
After a reliability study involving the P300, a more specific set of guidelines was also developed 
[19].  These guidelines are to be followed in addition the general guidelines proposed above:   
1.  Single trials vs. averages:  Single trials give more reliable estimates of P300 than 
averages.  This is especially useful in latency estimates.  However, single trials are more 
susceptible to background EEG noise and may provide issues in estimating amplitude.  
Therefore, both single trials and averages should be analyzed. 
2.  Filters:  Filters may be used to increase the signal-to-noise ratio of the system and 
improve P300 detection.  Appropriate frequency filters may have an upper cutoff point as 
low as 3 Hz for single trials and 6 Hz for averages.  Filters may also be used for scalp 
distribution (vector filters) and latency analysis.  Characteristics of both the P300 signal 
as well as the noise must be considered. 
3.  Signal detection algorithms:  The best results are obtained with algorithms that use the 
most information in defining P300.  Optimization techniques are also helpful but must be 
used with caution as they often require a validation procedure.   
4.  Analysis of scalp distribution:  A univariate analysis of variance (ANOVA) model is 
inappropriate to analyze scalp distribution.  To interpret different electrode locations a 
multivariate model should be used.   
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5.  Multiple analyses:  Several measurement procedures should be used in order to 
strengthen conclusions. 
6.  Multiple sessions:  If subjects are run in multiple sessions to obtain a sufficient 
number of trials each session should contain all experimental and control conditions.  If 
this is not possible, random experimental designs should be used.  Data obtained in 
different sessions should be analyzed separately and pooled only when similar results are 
obtained.   
3.9 Initial Studies of the P300 in Brain Computer Interfaces 
Initial spelling programs were tested by Farwell and Donchin (1988) in which the purpose of the 
study was to determine whether four mentally intact young adults could use a version of the 
oddball paradigm to communicate a five letter word to a computer.    Ag-AgCl electrodes were 
placed at the Pz site and referenced to linked mastoids.  The Pz location was chosen as this is the 
site of the largest P300 amplitude in young adults.  Electrode impedance remained below 5 kilo-
ohms (kΩ) [21]. 
The first area addressed by the study was to determine whether the P300 can be used as a switch 
to make a choice.  It was determined that the P300 can act as a binary switch as well as allow for 
the choice of one item out of a number of distinct items (1 letter or word out of 36 letters or 
words in this design).  The P300 can be used for categorization, provided that one of the 
categories is presented at a lower frequency.  The use of short inter-stimulus intervals (shorter 
than the latency of P300) does not interfere with elicitation of the P300.  As such, the P300 may 
be used to respond to task-relevant events.  It is important to note that the use of the P300 as a 
communication channel is dependent on the signal to noise ratio of the overall system and signal 
averaging is required.  In addition, detection methods vary in their effectiveness and alternative 
algorithms may be more effective in certain cases [21].   
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3.9.1 Early Results of P300 in ALS Populations 
Sellers et al. examined the use of the P300 Speller as described by Farwell and Donchin [21] in 
individuals with ALS.  15 individuals with ALS and one with a brainstem stroke were asked to 
use the P300 Speller in two sessions approximately six weeks apart.  Nine of the people were able 
to reach levels of accuracy greater than 75%.  The remaining individuals were unsuccessful using 
the program (accuracy level < 50%).   However, all seven of these users were either locked-in at 
the time of testing or were only able to communicate with their primary caregiver.  Each user’s 
waveforms were unique, as is expected in P300 trials.  Individual’s waveforms were similar over 
time, indicating that the P300 response does not habituate and remains stable over a period of 
weeks [13].   
Moving from a laboratory to a home environment introduces additional complications.  
Ventilators may introduce either electrical or mechanical artifacts as well as movements of the 
head.  These disturbances can manifest as frequency drift.  In locked-in individuals there are 
concerns with perceptual and cognitive abilities.  It is not truly known whether the person is 
attentive, can see the display, or attend to the correct character.  In addition, the level of cognitive 
ability is unknown [13].   
3.10 Summary 
Individuals with ALS lose the ability to communicate through traditional motor output pathways 
as the disease progresses.  A BCI allows for partial restoration of communication.  While there 
are many methods of obtaining brain signals, EEG can be accurately used to obtain an electrical 
signal from the brain without the need for invasive surgery.  In particular, a P300-based BCI can 
be used by individuals with severe disabilities to control a computer without additional training.  
Further research involving individuals with ALS may lead to unique classification methods which 
could help to improve the system for this population. 
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4. PROPOSED &EW APPROACH 
4.1 Hypothesis 
Though spelling ability and characteristics of the P300 waveform (including latency and 
amplitude) differ between healthy controls and individuals with ALS, decline in physical function 
should not impact the ability of an individual to use a BCI system. 
4.2 Technique 
To determine whether P300 signals are adequately detected by a commercial electrode cap, an 
electrode test system will be designed for use prior to subject use of the BCI system.  This test 
system will allow the session administrator to determine whether each of the 8 electrodes is 
functioning at full capacity. 
The P300 Speller and BCI2000 [8] will be used to evaluate an individual’s ability to 
communicate using a P300-based BCI as determined through spelling accuracy.  Analysis will be 
completed in MATLAB to determine individual and group characteristics of the P300 waveform 
across 8 electrode channels.   
  
5. DEVELOPME&T
5.1 Rationale 
The goal of the electrode test system is to design a device which allows each electrode to be 
examined for functionality.
testing or subject frustration with the system
5.2 Design 
The electrode test system should be able to acquire and reproduce signals from a signal generator.  
It should be flexible such th
testing without harm.  As shown in 
embedded in the commercial cap through individual wires.  Each electrod
to the DATAQ acquisition box, which translates the signal to acquisition software on a computer
The signal can then be stored for further analysis.  
Figure 9:  Block diagram of an electrode test system
 OF A TEST SYSTEM 
  If electrodes are broken or functioning incorrectly, unnecessary 
 may result. 
at a subject already wearing the electrode cap could perform the 
Figure 9, a signal generator is attached to the electrodes 
e sends a signal output 
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5.2.1 Testing a Single Electrode 
A signal passed through an individual electrode should be visible from a data acquisition system.  
A single electrode was disconnected from the electrode cap and placed in the system as shown in 
Figure 9.  The incoming wire was attached to a signal generator producing a sine wave.  Because 
an electrode in the cap is connected to both a reference and a ground, the single electrode was 
grounded to the DATAQ signal acquisition box and referenced to a second electrode.  A picture 
of the single electrode setup is shown in Figure 10.   
 
Figure 10:  Testing setup for a single electrode system. 
5.2.2 Testing of the Electrode Cap 
To test the entire electrode cap for functionality, all 10 electrodes (8 signal, 1 ground, and 1 
reference) should be attached to the DATAQ signal acquisition box.  However, the DATAQ box 
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only allows for 4 inputs.  Thus, for the purposes of this initial system design, only 4 channels 
were tested.  All 10 channels could be tested by moving the leads to additional locations on the 
cap. 
The incoming wires to the electrodes were attached to a signal generator producing a sine wave at 
amplitude of 2 V peak to peak and frequency of 1 Hz as shown in Figure 9.  The 4 electrodes 
were grounded to the DATAQ signal acquisition box.  All electrodes remained in the cap for the 
duration of the testing to ensure that a subject would be able to wear the cap and perform the test 
at the same time.  A picture of the 4 electrode test system is shown in Figure 11.   
 
Figure 11:  Testing setup for a 4 electrode system. 
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6. METHODS 
6.1 Subjects 
Four able-bodied and eight individuals with ALS from the Philadelphia community participated 
in the trials.  One user had previous experience with the P300 Speller paradigm.  The study was 
approved by the Drexel University College of Medicine Institutional Review Board, and each 
user gave informed consent.  If the subject was unable to sign his/her own consent, it was signed 
by a legally authorized representative.  The subject’s acceptance of the consent was determined 
through a traditional yes/no response as reported by the legally authorized representative.  The 
approved consent is presented in Appendix B. 
6.2 Data Acquisition and Signal Processing 
EEG was recorded using a cap (Electro-Cap International, Inc.) embedded with 8 electrodes 
distributed according to a modified International 10-20 system.  The size of the cap used was 
based on the circumference of the subject’s head.  All 8 channels were grounded to the right 
mastoid and referenced to the left mastoid.  The EEG signal was bandpass filtered 0.1-60 Hz, 
amplified with a Guger Technologies amplifier (20,000x), digitized at a rate of 240 Hz, and 
stored.  All aspects of data collection were controlled by the BCI2000 system [8].  
6.3 Task, Procedure, and Experimental Design 
The subject was positioned approximately 1 meter from a computer screen to view the matrix 
display.  In cases where the individual was restricted to a wheelchair or a bed the subject was 
made as comfortable as possible and the screen was positioned for ease of viewing.  A 6 x 6 
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matrix consisting of white characters on a black background was displayed on the screen.  An 
example setup is shown in Figure 12. 
a    b  
Figure 12:  BCI setup for (a) the individual wearing the electrode cap and (b) the viewing screen, computer 
system, and amplifier.  
Each subject was fitted with an electrode cap.  Each electrode was injected with electrode gel 
(Electro-Cap International, Inc.) until the impedance was below 10 kΩ as shown in Figure 12a.   
The user’s task was to complete a copy-spelling session in which the target letter is specified to 
allow for offline analyses.  The user was asked to focus attention on one letter of the matrix and 
count the number of times the row or column displaying that target letter was intensified.  The 
rows and columns of the matrix were intensified in a random sequence such that each of the 6 
rows and 6 columns were intensified once before any were repeated.  At the start of each run, the 
first letter of a word was presented in parentheses at the end of the word.  This letter was the 
target letter.  After 14 row and column intensifications (epochs) the classifier made a decision on 
the letter chosen.  The sample rate was 256 Hz.  There was a 4 second (s) delay before and after 
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the test sequence began with a stimulus duration of 3 sample blocks and an inter-stimulus interval 
of 4 sample blocks
3
.  After a 2.5 s delay, the letter is reported to the administrator of the test.  An 
additional 2.5 s later the next character in the word was presented in parentheses (for a total time 
between characters of 5 s).  This process continued until the entire word was spelled.  The 
sentence “THE QUICK BROWN FOX JUMPS OVER THE LAZY DOG” was spelled 
completely for classification.  The subject was not given the opportunity to correct for any 
mistakes.  For a detailed protocol, refer to Appendix C. 
6.3.1 P300 Spelling Accuracy 
The ability of an individual to use the system can be judged by the number of letters correctly 
selected by the subject out of the phrase “OVER THE LAZY DOG.”  The percent correct is the 
number of letters chosen correctly divided by the number of letters in the phrase (14), multiplied 
by 100 [9, 10]. 
6.3.2 P300 Spelling Accuracy Given a Change in Electrode Location 
Further experimentation was done on 4 subjects in whom the ground and reference mastoids were 
placed (1) on the left and right mastoid, (2) directly below the ear, and (3) 5 cm below the ear on 
the lower neck.  The subject was asked to complete a copy-spelling session by spelling “THE 
QUICK BROWN FOX JUMPS” with the electrodes in each of the three locations.  The predicted 
percent correct and number of flashes to achieve this percentage were recorded.   
The Coefficient of Variance (CV) was computed for each subject.  It is defined as the ratio of the 
standard deviation to the mean of the data.  A CV less than 0.15, or 15%, indicates acceptable 
variance in moving the electrodes.   
                                                     
3
 In runs for BCI015 and all runs for electrode placement testing the stimulus duration was changed to 6 
sample blocks and the inter-stimulus interval was changed to 2 sample blocks. 
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6.3.3 Analysis of the P300 Waveform 
Analysis of the P300 waveforms was conducted using the MATLAB P300 GUI in the BCI2000 
software [23] as well as the MATLAB Offline Analysis program [8].  Maximum amplitude is 
defined as the maximum positive amplitude value which the waveform takes over an 800 ms 
interval for a specific channel.   
The coefficient of determination (r
2
) value is a statistical measure which calculates the fraction of 
the total signal variance that is accounted for by the spelling task.  Maximum r
2
 value is defined 
as the maximum r
2
 value which the waveform takes over an 800 ms interval for a specific 
channel.   
A two-tailed two-sample t-test was used to determine whether differences in latency and 
amplitude in the P300 signal between controls and individuals with ALS were significant 
(p<0.05).  In examining the latency of the P300 signal, a preliminary test for the equality of 
variances indicated that the variances of the two groups were significantly different (F=5.246, 
p=.033). Therefore, a two-sample t-test was performed that assumed unequal variances.  In 
examining the amplitude of the P300 signal, a preliminary test for the equality of variances 
indicated that the variances of the two groups were not significantly different (F=0.621, p=.377). 
Therefore, a two-sample t-test was performed that assumed equal variances.   
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7. RESULTS 
7.1 Test System 
The electrode test system can be used to determine whether electrodes are functioning properly 
before a subject uses the cap.  Figure 13 shows the first 100 data points obtained from the 
DATAQ acquisition software.  A longer duration of signal acquisition is shown in Appendix D. 
 
Figure 13:  Amplitude of a sine wave signal in a single electrode over time for the designed test system. 
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Figure 14 shows the first 100 data points obtained from the DATAQ acquisition software for 
Channels 5, 6, 7 and 8 (the four channels chosen for testing purposes).  The peak to peak voltage 
for this time period is 1.89 V for Channels 5, 6 and 7 and 1.88 V for channel 8.  A longer duration 
of signal acquisition is shown in Appendix D. 
 
Figure 14:  Amplitude of a sine wave signal in Channels 5, 6, 7, and 8 over time for the designed test 
system. 
7.2 P300 Spelling Accuracy 
The ability of an individual to use the system can be judged by the number of letters correctly 
selected by the subject out of a set sequence of letters.  The subject number, gender, age, 
diagnosis, ALSFRS score (if applicable) and percent correct for all subjects is shown in Table 1.  
See Appendix E for an extended table indicating date of symptom onset, date of diagnosis, and 
medications.   
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Table 1 Spelling accuracy as determined by percent correct for all subjects. 
Subject Gender Age Diagnosis ALSFRS 
Percent 
Correct 
BCI004 M 55 ALS 18 93 
BCI006 M 54 ALS 27 86 
BCI007 F 66 ALS 27 71 
BCI008 F 57 ALS 33 64 
BCI009 M 54 ALS 1 100 
BCI011 F 48 ALS 34 100 
BCI012 M 50 ALS 1 79 
BCI013 M 38 ALS 11 100 
BCI001 F 43 Control NA 100 
BCI002 M 24 Control NA 100 
BCI003 M 22 Control NA 86 
BCI014 M 23 Control NA 100 
The ALSFRS is commonly used to indicate disease progression.  Figure 15 demonstrates the 
spelling accuracy of the subject as indicated by the percent correct as a function of the ALSFRS 
score of the subject.  Controls are excluded from this analysis as all controls have full 
functionality in daily activities. 
 
Figure 15:  Spelling accuracy as indicated by percent correct vs. ALSFRS. 
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Changes occur in the brain as an individual ages.  Figure 16 shows spelling accuracy as a function 
of subject age for all subjects.  Males are indicated with a blue diamond while females are 
indicated with a red square.   
 
Figure 16:  Spelling accuracy as indicated by percent correct vs. subject age. 
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7.3 P300 Spelling Accuracy Given a Change in Electrode Location 
Table 2 shows the predicted percent correct and the number of epoch flashes to achieve that 
accuracy as determined by the BCI2000 software.  Data is presented for all electrode locations for 
which the subject participated in the trial.  Peak values are shown in Appendix G. 
Table 2:  Predicted percent correct spelling and the number of flashes to achieve accuracy based on ground 
and reference electrode location in healthy controls and individuals with ALS. 
Subject Disease State Position Predicted Percent Correct 
&umber of 
Flashes 
BCI006 ALS 1 100 13 
BCI006 ALS 2 95 10 
BCI006 ALS 3 90 13 
BCI012 ALS 1 90 13 
BCI012 ALS 2 90 11 
BCI012 ALS 3 100 7 
BCI014 Control 1 100 3 
BCI014 Control 2 100 7 
BCI014 Control 3 100 5 
BCI015 Control 1 100 6 
BCI015 Control 2 100 4 
Table 3 indicates the CV for both controls and ALS subjects.  The CV for the latency of the peak 
amplitude of the P300 signal, peak amplitude of the P300 signal, and peak r
2
 value of the P300 
signal are calculated.   
Table 3:  CV values for all subjects for the latency, peak amplitude, and peak r
2
 value of the P300 signal. 
Subject Latency Peak Amplitude Peak r
2
 
BCI006 0.152 0.144 0.518 
BCI012 0.386 0.125 0.344 
BCI014 0.289 0.125 0.059 
BCI015 0.495 0.077 0.573 
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7.4 Analysis of the P300 Waveform 
The r
2
 plot demonstrates the fraction of the total signal variance that is accounted for by the 
spelling task.  Here, condition 1 is the presence of a target letter and condition 2 is the presence of 
a non-target letter.  Figure 17 shows the r
2
 values over 1000 ms and 8 channels for control subject 
BCI001.   
 
Figure 17:  r
2
 plot for control subject BCI001. 
Analysis of the r
2
 values can also be performed across individual electrode channels.  Figure 18 
shows the amplitude of the P300 signal and the statistical measure r
2
 between the target (red) and 
non-target (green) letter for control subject BCI001 over 800 ms.  Channels 13, 14, 15, and 16 
correspond to Channels 5, 6, 7, and 8, respectively in Figure 17.   
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a b   c  
d  e  f  
g  h  
Figure 18:  Individual waveforms for control subject BCI001 for (a) Channel 1, (b) Channel 2, (c) Channel 
3, (d) Channel 4, (e) Channel 5, (f) Channel 6, (g) Channel 7, and (h) Channel 8. 
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Figure 19 shows the r
2
 values over 1000 ms and 8 channels for ALS subject BCI004.   
 
Figure 19:  r
2
 plot for ALS subject BCI004. 
Figure 20 shows the amplitude of the P300 signal and the statistical measure r
2
 between the target 
(red) and non-target (green) letter for ALS subject BCI004 over 800 ms.  Channels 13, 14, 15, 
and 16 correspond to Channels 5, 6, 7, and 8, respectively in Figure 19.   
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a b c  
d e f  
g h  
Figure 20:  Individual waveforms for ALS subject BCI004 for (a) Channel 1, (b) Channel 2, (c) Channel 3, 
(d) Channel 4, (e) Channel 5, (f) Channel 6, (g) Channel 7, and (h) Channel 8. 
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Control subject BCI001 and ALS subject BCI004 are presented as representative data from the 
two subject groups.  The r
2
 plots and individual waveforms are presented for all subjects in 
Appendix F.  Appendix G contains a listing of the peak amplitude, r
2
 value and time by channel 
for each subject.   
A two-sample t-test was performed to test the null hypothesis that there was no difference in the 
latency of the peak amplitude of the P300 signal in controls and individuals with ALS.  The mean 
latency for controls (M=301.75, SD=49.21, N=4) was significantly later than the mean latency for 
individuals with ALS (M=205.08, SD=21.49, N=8) using the two-sample t-test for unequal 
variances, t(4)=2.78, p=0.020.   
A two-sample t-test was performed to test the null hypothesis that there was no difference in the 
peak amplitude of the P300 signal in controls and individuals with ALS.  The mean peak 
amplitude for controls (M=3.02, SD=1.06, N=4) was not significant when compared to the mean 
peak amplitude for individuals with ALS (M=4.07, SD=1.34, N=8) using the two-sample t-test 
for equal variances, t(10)=2.23, p=0.20. 
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8. DISCUSSIO& 
8.1 Test System 
The initial test system consists of a single electrode attached to a signal generator and data 
acquisition system.  It is important that the electrode be able to maintain an alternating current 
(AC) signal, as the signal generated in the brain and elucidated with EEG is alternating in nature.  
Figure 13 shows that a single electrode can in fact be used to record a continuous AC signal as a 
sine wave signal can be viewed with the data acquisition software.   
With this signal acquisition, it was then possible to extend the system to cover 4 electrodes at 
once and determine the actual capabilities of the electrodes.  Figure 14 shows the consistency in 
the applied signal over the 4 examined electrodes.  Appendix D shows that the electrodes can 
adjust to changes in signal amplitude.  Thus, as changes occur to the signal within the brain, the 
electrodes are able to adapt and report back an adequate response.   
Peak to peak voltages indicate that 6% of the signal is lost in channels 5, 6, and 7 and 5% of the 
signal is lost in channel 8.  This loss demonstrates that while the electrodes are sensitive there is 
some signal loss, which may cause EEG to lose part of a signal arising from the brain.  
One limitation of this test system was the DATAQ acquisition box.  A larger box consisting of 10 
channels would allow all electrodes to be tested at once.  In order for such a test system to be 
used in a home or clinic setting it must be possible to test all of the electrodes simultaneously.  
Another limitation was the inability to read the signal with the available EEG software.  
Additional studies must be performed to test the ability of EEG to read a signal generated external 
to the brain.   
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8.2 P300 Spelling Accuracy 
An individual is considered to be a responder if he/she obtains 75% spelling accuracy. This is the 
minimum percentage deemed necessary to understand communication efforts.  All controls were 
responders, with the lowest ability at 86%.  This indicates that the system does work in a healthy 
population.  Only 2 individuals with ALS were non-responders (BCI008 and BCI007 at 64% and 
71%, respectively).  Therefore, the majority of individuals with ALS were able to use the BCI 
system effectively.   
There is no correlation between spelling ability and ALSFRS.  Thus, individuals who are 
extremely disabled are still able to use the BCI.  However, it is important to note that the 
ALSFRS does stop at a particular point and many individuals continue to survive and progress 
past an ALSFRS score of 1 or 0.  Therefore, to truly evaluate disease progression and its effects 
on spelling ability, a new scale or method of monitoring disease progression should be created 
beyond the ALSFRS. 
In combining healthy controls and individuals with ALS, there is no correlation between spelling 
ability and age in either males or females.  All individuals are able to use the system which shows 
that although brain function may change over time, the brain is consistently able to obtain a P300 
response.   
8.3 P300 Spelling Accuracy Given a Change in Electrode Location 
Healthy controls were able to obtain 100% spelling accuracy in all ground and reference electrode 
locations with a maximum of 7 flashing sequences.  Both individuals with ALS were considered 
responders at all locations but only obtained 100% accuracy at one location (location 1 for 
BCI006 and location 3 for BCI012).  
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The ability to accurately use the system with changes in the placement of ground and reference 
electrodes and the number of flashing sequences demonstrates that the system does not need to be 
static.  
Table 2 shows that the ideal location and number of sequences will be individualized, and can be 
changed to fit individual preferences and capabilities. The ability to move these electrodes allows 
greater comfort for individuals who wear glasses or are extremely disabled and must 
communicate from a bed or wheelchair.  The ability to reduce the number of flashing sequences 
provides faster communication.  Greater overall comfort and satisfaction ensures that the 
individual is more willing to use the BCI as an option for communication.    
For all subjects the CV for the latency of the peak amplitude was significant and the CV for the 
peak amplitude was not significant.  This indicates that although the different electrode locations 
showed spikes in the P300 signal at different times, the peak amplitude remained consistent.  
Therefore, an individual does have stability in P300 amplitude.  With the exception of subject 
BCI014, the CV for the peak r
2
 value varies significantly across electrode locations.  This 
possibly shows that although the target amplitude remains the same across locations, there are 
differences in the way the target and non-target signals are characterized.   
8.4 Analysis of the P300 Waveform 
Figure 17 and Figure 19 were chosen as representative r
2
 plots for a healthy control and an 
individual with ALS, respectively.  In general, individuals with ALS show lower r
2
 values across 
the 8 electrode channels.   In 3 out of the 4 healthy controls, activity can be visualized across all 
electrodes.  However, in 7 out of the 8 individuals with ALS, activity can be visualized primarily 
in Channels 1-4.  This difference does not, however, inhibit the ability of an individual with ALS 
to accurately use the P300 Speller. 
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Examination of the individual waveforms (such as those in Figure 18 and Figure 20) further 
shows the differences between subjects.  In some cases the waveforms are clean with consistent 
spikes indicating the response to a target letter.  In other individuals the waveforms appear to 
have a great deal of noise or EEG artifacts and it may be difficult to determine with certainty 
when the target letter is being selected.   
A two-sample t-test revealed that the latency of the peak amplitude P300 signal was significantly 
later in healthy controls than individuals with ALS.  Although the P300 is defined as the peak 
amplitude between 220 and 500 ms, the healthy controls had a mean latency of 301.75 ms, 
indicating that controls are able to identify the target letter and obtain a regular brain response.  
With a mean latency of 205.08, individuals with ALS respond faster to target stimuli. This may 
indicate a difference in brain structure or electrical wiring within the brain which causes the 
response to be processed more quickly.    
A second two-sample t-test showed that the peak amplitude of the P300 signal was not 
significantly different between healthy controls and individuals with ALS.  Thus, although the 
latency may change, the amplitude response to target stimuli does not.  The same level of 
excitement is elicited in both controls and individuals with ALS.   
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9. CO&CLUSIO&S A&D RECOMME&DATIO&S TO THE FIELD 
Individuals with ALS are able to use the P300-based BCI for communication.  Spelling ability is 
not correlated with ALSFRS or age, indicating that individuals of all ages and levels of disability 
may be able to use the system.  In addition, testing the ability to move the ground and reference 
electrodes demonstrates the flexibility of the system.  This allows for greater comfort and 
satisfaction with the system as a communication tool.   
There are differences in the signals produced by healthy controls and individuals with ALS.  The 
latency of the peak amplitude P300 signal was significantly later in controls compared to 
individuals with ALS.  On the other hand, the peak amplitude itself was not significantly 
different.  This examination shows that there may be differences in electrical wiring within the 
brains of individuals with ALS.  These differences do not, however, translate to an inability to use 
the BCI for communication.   
The BCI2000 system has been tested numerous times in healthy and disease populations.  
Therefore, the main approach to this study was to assume that the BCI system worked well and 
could accurately classify EEG signals.  Differences between healthy controls and individuals with 
ALS provide further motivation to study the system in a disease population and create mock 
systems.    
The original design of the test system is adequate for determining functionality and flexibility of 
the individual electrodes.  In order to be a true mock system, coils should be used to induce a 
signal.  This would more accurately reflect the signal arising through the skull to the electrode 
surface.  Designing a mock skull would allow the researcher to test different issues in brain 
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functionality and different disease conditions.  This may allow the researcher to determine the 
feasibility of a diseased individual using the BCI without testing the BCI on the individual.    
To fully understand the differences between healthy controls and individuals with ALS additional 
data should be collected.  In particular, a wider range of disease states and more individuals who 
are locked-in should be examined.  Additional data will help to determine whether differences are 
individual or based on disease with certainty.   
Work with locked-in individuals demonstrates the need for early implementation of the BCI.  
Individuals with ALS should be screened on a regular basis (every 6 months or once a year, 
depending on disease progression) to determine their ability to achieve spelling accuracy.  Once 
an individual becomes locked-in it is difficult to determine whether he/she understands how to 
use the system.  Early screening will ensure that the use of the system is understood.  In addition, 
collection of data on a regular basis across various levels of disease progression would help to 
track changes in brain function over time. 
Perhaps the most important recommendation to the field comes directly from the individuals 
using the system.  Caregivers often assume that individuals wish to communicate their daily 
needs.  While this is true, people also want to be able to communicate their desires and, most 
importantly, to have regular discussions with their loved ones.  It is important that in addition to 
focusing on the technology, researchers also examine patient comfort and ease of use.  The ideal 
BCI will be easy to understand, easy to implement, and will allow the individual freedom to 
control their world as they were once able to do.   
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APPE&DIX A:  ALS FU&CTIO&AL RATI&G SCALE 
1.  SPEECH  
     4    Normal speech processes 
     3    Detectable speech disturbance 
     2    Intelligible with repeating 
     1    Intelligible with non-vocal communication    
     0    Loss of useful speech    
8. WALKING 
     4    Normal 
     3    Early ambulation difficulties 
     2    Walks with assistance 
     1    Non-ambulatory functional movement only 
     0    No purposeful leg movement 
2. SALIVATION 
     4    Normal 
     3    Slight but definite excess saliva in mouth; 
           may have night time drooling 
     2    Moderately excessive saliva; may have minimal drooling 
     1    Marked excess of saliva with some drooling 
     0    Marked drooling; requires constant tissue 
           or handkerchief 
9. CLIMBING STAIRS 
     4    Normal 
     3    Slow 
     2    Mild unsteadiness or fatigue 
     1    Needs assistance 
     0    Cannot do 
 
3. SWALLOWING 
     4    Normal eating habits 
     3    Early eating problems-occasional choking 
     2    Dietary consistency changes 
     1    Needs supplemental tube feeding 
     0    NPO   
 
4. HANDWRITING 
     4    Normal 
     3    Slow or sloppy; all words legible 
     2    Not all words are legible 
     1    No words are legible, but can still grip pen 
     0    Unable to grip pen 
ALSFRS-R Respiratory Subscale 
The following questions are to be asked after completion of the main 
portion of the ALSFRS (questions 1-10) 
5a. CUTTING FOOD AND HANDLING UTENSILS 
Subjects without gastrostomy.  
     4    Normal 
     3    Somewhat slow and clumsy, but no help needed 
     2    Can cut most foods, although slow and clumsy; some help       
           needed 
     1    Food must be cut by someone, but can still feed slowly 
     0    Needs to be fed 
R-1. DYSPNEA 
     4    None 
     3    Occurs when walking 
     2    Occurs with one or more of the following: eating, bathing,    
           dressing (ADL) 
     1    Occurs at rest;  when either sitting or lying 
     0    Significant difficulty, considering using mechanical  
           respiratory support 
5b. CUTTING FOOD AND HANDLING UTENSILS 
Subjects with gastrostomy.  
     4    Normal  
     3    Clumsy, but able to perform all manipulations  
           independently 
     2    Some help needed with closures and fasteners 
     1    Provides minimal assistance to caregiver 
     0    Unable to perform any aspect of the task 
 
R-2. ORTHOPNEA 
     4    None 
     3    Some difficulty sleeping at night due to shortness of breath,    
           does not routinely use more than two pillows 
     2    Needs extra pillows in order to sleep (more than two) 
     1    Can only sleep sitting up 
     0    Unable to sleep 
6. DRESSING AND HYGIENE 
4    Normal function 
3    Independent self care with effort or decreased efficiency 
2    Intermittent assistance or substitute methods 
1    Needs attendant for self-care 
0    Total dependence 
 
 
R-3. RESPIRATORY INSUFFICIENCY 
     4    None 
     3    Intermittent use of BiPAP 
     2    Continuous use of BiPAP during the night 
     1    Continuous use of BiPAP during day and night 
     0    Invasive mechanical ventilation by intubation or   
           tracheotomy 
7. TURNING IN BED AND ADJUSTING BED CLOTHES 
4    Normal 
3    Somewhat slow and clumsy, but no help needed 
2    Can turn alone or adjust sheets, but with great difficulty 
1    Can initiate, but not turn or adjust sheets alone 
0    Helpless 
 
 
ALSFRS Score _____________/48 
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APPE&DIX B:  IRB APPROVED PROTOCOL 
Drexel University College of Medicine 
Consent to Take Part In a Research Study 
 
 
 
1. Subject Name:   
________________________________________________________________ 
 
2. Title of Research: EEG-Based Brain-Computer Interface Project for Individuals 
With ALS 
 
3. Investigator's Name:  Terry Heiman-Patterson, MD 
 
4. Research Entity:  This research study is being done by a researcher of the 
Philadelphia Health & Education Corporation, which does business under the name 
Drexel University College of Medicine.  Drexel University is a separate corporation 
and is not involved in or a party to this research study. 
 
5. Consenting for the Research Study:  This is a long and an important document.  If 
you sign it, you will be authorizing Drexel University College of Medicine and its 
researchers to perform research studies on you.  You should take your time and 
carefully read it.  You can also take a copy of this consent form to discuss it with your 
family member, physician, attorney or anyone else you would like before you sign it.  
Do not sign it unless you are comfortable in participating in this study.  
 
6. YOUR RIGHT TO PRIVACY AND CONFIDENTIALITY: Very specific 
information on your right to privacy and the confidentiality of the use and disclosure 
of your personal health information can be found at the end of this consent form.  We 
need your authorization to use and disclose the health information that we may 
collect about you during this research study.  To be in this research study you must 
read and sign the authorization at the end of this consent form.  
 
7. PURPOSE OF RESEARCH: 
 You are being asked to participate in a research study.  The purpose of this study is 
to investigate if using EEG-based Brain Computer Interface technology is a suitable 
and reasonable choice as a communication solution for individuals with ALS. You 
are being asked to participate either as an individual with a diagnosis of probable or 
definite ALS, or as a control subject. ALS is a disease that affects the nerves which 
control muscles. As the disease progresses the nerves die and the patients loose their 
ability to control the muscles movements. In this project we are trying to see if this 
new technology will be a helpful method of communication for ALS patients.   
 EEG-based Brain Computer Interface technology uses the EEG to help click on the 
setup area (like a computer mouse and keyboard) to spell or press certain buttons, 
that will aid communication.  
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 The control subjects will help us find out whether any hardship in doing the test is 
due to the disease or the technique itself. Your decision to either participate or not to 
participate will not influence your medical care or any further medical treatment you 
may need. Approximately 50 people, between the ages of 18 to 90 years, will be asked 
to participate in this study.  
 
8. PROCEDURES AND DURATION: 
You understand that all of the following things that will be done to you are 
experimental.  
The initial training will be conducted in an exam room in the Neurology outpatient 
clinic. 
If you participate in the study, you understand that you will be asked to do the       
following things: 
a) You will be asked to fill out a questionnaire and be evaluated by a functional 
rating scale. This functional scale asks questions about how you are able to take 
care of yourself. This will take about five minutes. 
b) Next, your EEG, or brainwaves, will be recorded. To do this, you will sit in a 
comfortable chair or your own wheelchair approximately 3 feet away from a 
computer monitor.  Up to 64 scalp electrodes will be placed on your head,  the 
electrodes are pre-fixed in an electrode cap (e.g., Electro-Cap, Inc.). A small 
amount of an odorless, colorless, water-soluble gel is applied to each electrode. 
The only discomfort you may experience during this procedure is the transient 
coolness of the gel. You will not feel anything unusual during the recording. The 
electrodes can be placed directly over your hair. There is no need to shave the 
area.  
c) You will then be asked to follow a series of instructions while the EEG is being 
recorded. These instructions include; counting the number of times a particular 
letter or symbol is seen on the screen or count the number of times a particular 
tone is heard. Like most standard noninvasive electroencephalograms (EEGs), 
our procedure takes between one and one and one half hours including set up 
and clean up. Water, shampoo, a towel and hair dryer will be provided if you wish 
to remove the gel at the end of the session.  
d) Following this session, you will be asked to return for one more training and 
recording sessions, similar to the first. You  may also be asked if you would like 
to continue with further training and recording sessions in your home. You will 
decide on how many sessions you need to feel comfortable with using the 
machine.  These sessions at home will also be similar to the outpatient clinic 
sessions and will take about one and one half hours.   
e) If you already use a communication device, you may be requested to copy the 
same activity with your usual means of communication for time, efficiency, and 
proficiency comparisons.  
 You may withdraw at any time.  
 
 The data gathered will also be sent to our collaborating site, Wadsworth Center, for 
data analysis. 
 
 
9. RISKS AND DISCOMFORTS/CONSTRAINTS: 
The BCI system uses clinical-grade equipment. Thus, the study risk is no greater 
than the extremely small risk associated with routine clinical EEG recording. The 
only discomfort you may experience during this procedure is the transient coolness 
of the gel.  
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We will try to accommodate and have you either sitting up or semi-reclined to make 
you comfortable during the test. However, if you do need to move or change 
position, the test will be stopped until you are ready to start.  
 
10. UNFORESEEN RISKS: 
Participation in this study may include unforeseen risks. If unforeseen risks are seen, 
they will be reported to the Office of Regulatory Research Compliance.  
 
11. BENEFITS: 
There may be no direct benefits to you from participating in this study. 
       
12. ALTERNATIVE PROCEDURES/TREATMENT: 
     The alternative is not to participate in this study.  
 
13. REASONS FOR REMOVAL FROM STUDY: 
You may be required to stop the study before the end for any of the following 
reasons: 
a) Change in medical condition; 
b) If all or part of the study is discontinued for any reason by the investigator, 
university authorities, or government agencies; or 
c) Other reasons, including new information available to the investigator or 
harmful unforeseen reactions experienced by the subject or other subjects in 
this study. 
 
14. VOLUNTARY PARTICIPATION: 
 You understand that being in this study is voluntary for the ALS subjects as well as 
the controls.  Your health care will not be affected in any way if you decline to be in 
or later withdraw from the study. You can refuse to be in the study or stop at any 
time without the loss of the care benefits to which you are entitled if you should 
suffer an injury as result of this trial.   
 
15. RESPONSIBILITY FOR COST 
You will not be responsible for the costs of the procedures strictly related to this 
study. You will not receive any payment for taking part in this study.  
 
16. IN CASE OF INJURY:   
Treatment for Injury: If you have any questions or believe you have been injured in 
any way by being in this research study, you should contact Dr. Terry Heiman-
Patterson, MD at telephone (215)-762-5186.  However, no payment or compensation 
will be provided for injury, illness or other loss resulting from your being in this 
research study.  If you are injured by this research activity, medical care including 
hospitalization is available, but may result in costs to you or your health insurance.  
If you are injured or have an adverse reaction, you should also contact the Office of 
Regulatory Research Compliance 215-255-7857. 
17. CONFIDENTIALITY AND PRIVACY: 
This section gives more specific information about the privacy and confidentiality of 
your health information.  It explains what health information about you will be 
collected during this research study and who may use, give out and receive your 
health information.  It also describes your right to inspect your medical records and 
how you can revoke this authorization after you sign it. 
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By signing this form, you agree that your health information may be used and 
disclosed during this research study.  Your health information may be disclosed or 
transmitted electronically.   We will only collect information that is needed for the 
research study.  Your health information will only be used and given out as explained 
in this consent form or as permitted by law. 
In any publication or presentation of research results, your identity will be kept 
confidential. 
 
A. Individually Identifiable Health Information that will be collected 
The following personal health information about you will be collected and 
used during the research study and may be given out to others:    
 Your name, address, telephone number, date of birth; 
 Personal medical history; 
 Information from physical exams and other tests or procedures 
described in this consent form. 
 Information learned during telephone calls, surveys, questionnaires 
and office visits done as part of this research study; 
 Information in medical records located in your doctor’s office or at 
other medical facilities you may have received treatment. 
 
B. Who will see and use your health information within Drexel University 
College of Medicine.   
The research study investigator and other authorized individuals involved in 
the research study at Drexel University College of Medicine will see your 
health information and may give out your health information during the 
research study.  These include the research investigator and the research 
staff, the institutional review board and their staff, legal counsel, research 
office and compliance staff, officers of the organization and other people who 
need to see the information in order to conduct the research study or make 
sure it is being done properly.      
C. Who else may see and use your health information. 
Other persons and organizations outside of Drexel University College of 
Medicine may see and use your health information during this research 
study.  These include:  
• Governmental entities that have the right to see or review your health 
information, such as the Office of Human Research Protections. 
• Doctors and staff at other places that are participating in the research 
study. 
• The Laboratory of Nervous System Disorders (LNSD) of the 
Wadsworth Center of the New York State Department of Health will 
be assisting in coordinating the study and analyzing the data.  
 
If your health information is given to someone not required by law to keep it 
confidential, then that information may no longer be protected, and may be 
used or given out without your permission. 
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D. Why your health information will be used and given out. 
Your health information will be used and given out to carry out the research 
study and to evaluate the results of the study. 
E. If you do not want to give authorization to use your health information. 
You do not have to give your authorization to use or give out your health 
information.  However, if you do not give authorization, you cannot 
participate in this research study. 
F. How to cancel your authorization. 
At any time you may cancel your authorization to allow your health 
information to be used or given out by sending a written notice to the Office 
of Regulatory Research Compliance, 1601 Cherry Street, 3 Parkway, Suite 
10444, Philadelphia, Pennsylvania, 19102.  If you leave this research study, no 
new health information about you will be gathered after you leave.  However, 
information gathered before that date may be used or given out if it is needed 
for the research study or any follow-up.   
G. When your authorization ends 
Your authorization to use and give out health information will continue until 
you withdraw or cancel your authorization. After the research study is 
finished, your health information will be maintained in a research database.  
Drexel University College of Medicine shall not re-use or re-disclose the 
health information in this database for other purposes unless you give written 
authorization to do so.   However, the Drexel University College of Medicine 
Institutional Review Board may permit other researchers to see and use your 
health information under adequate privacy safeguards.  
H. Your right to inspect your medical and research records. 
You have the right to look at your medical records at any time during this 
research study.  However, the investigator does not have to release research 
information to you if it is not part of your medical record. 
18. OTHER CONSIDERATIONS: 
If you wish further information regarding your rights as a research subject or if you 
have problems with a research-related injury, for medical problems please contact 
the Institution's Office of Regulatory Research Compliance by telephoning 215-255-
7857. 
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19. CONSENT:          
• I have been informed of the reasons for this study. 
• I have had the study explained to me. 
• I have had all of my questions answered. 
• I have carefully read this consent form, have initialed each page, and have 
received a signed copy. 
• I authorize the use and disclosure of my personal health information as 
explained in this consent form. 
• I give consent voluntarily. 
 
 
____________________________________________   _______________ 
Subject or Legally Authorized Representative     Date 
 
_____________________________________________   ______________ 
Investigator or Individual Obtaining this Consent/Permission  Date 
 
______________________________________________  _______________ 
Witness to Signature        Date 
 
List of Individuals Authorized to Obtain Consent/Permission 
 
Name    Title   Day Phone #  24 Hr Phone # 
Terry Heiman-Patterson, MD Principal Investigator 215-762-5186  215-363-0153 
Anahita Deboo, MD  Co-Investigator 215-762-7037  215-762-7000 
Sara Feldman, PT  Key Personnel  215-762-5186  NA 
Christine Barr, RN  Key Personnel  215-762-5186  NA 
Mary Paolone, RN  Key Personnel  215-762-5186  NA 
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APPE&DIX C:  DETAILED PROTOCOL 
Method 1:  Original Electrode Positions 
a.  System Setup 
1. Open BCI2000 and select the P300 speller.   
2. Create a 6x6 matrix containing the letters A-Z, Sp (for space), and the numbers 1-9.    
3. Measure the circumference of the head to determine which cap size is needed (Red: 54-
58 cm, Red/Blue: 56-60 cm, Blue: 59-62 cm). 
4. Position the cap so that the current ear holes line up with the ears of the subject.  Roll the 
cap slightly inside out and place the front elastic directly above the eyebrows. 
5. Measure the distance between the nasion and Fz electrode.  The distance should be 
approximately 30% of the distance between the nasion and inion. 
6. Fill a syringe with electrode gel and place a blunt needle on the tip. 
7. Inject approximately 0.5 cc of electrode gel into each of the 8 electrodes.  Slowly 
withdraw the needle while injecting the gel. 
8. Examine the impedance of each electrode. 
9. Use the blunt end of the Q-tip to move the gel around within the electrode.  Inject 
additional gel onto the scalp.  Repeat steps 6 and 7 until the impedance in each electrode 
is below 10 kohm.   
 
b.  Initial Calibration 
The initial calibration is used to orient the user to the system and determine initial parameters. 
1. Explain the P300 speller to the subject.  A word will appear on the screen in yellow with 
one letter in parentheses.  The subject will find the letter in parentheses on the grid and 
focus on it.  Each time the letter turns white (flashes) the subject will count an instance of 
the letter to himself.   
2. Set the first word for the subject to spell to “THE”.   
3. Allow the subject to spell the entire first word.  Record what the subject has been told to 
spell and what the computer believes the subject is spelling. 
4. Change the word for the subject to spell to “QUICK”.  
5. Repeat step 3 until the subject has spelled “THE QUICK BROWN FOX JUMPS”. 
 
c.  Initial Parameters 
The initial parameters obtained will be used for the secondary calibration. 
1. Run P300_GUI in Matlab 2008. 
2. Select the 5 complete runs from the initial calibration. 
3. Generate feature weights for the initial calibration data. 
4. Save the *.mud and *.prm(v2) files. 
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d.  Secondary Calibration 
This calibration continues the initial calibration.  At this point the system should be able to detect 
the subject’s intent with at least some degree of accuracy.   
1. In the BCI2000 program, load the initial parameters.   
2. Set the first word for the subject to spell to “OVER”.   
3. Allow the subject to spell the entire first word.  Record what the subject has been told to 
spell and computer believes the subject is spelling. 
4. Change the word for the subject to spell to “THE”.  
5. Repeat step 3 until the subject has spelled “OVER THE LAZY DOG”. 
6. Determine the spelling accuracy of the subject.  The accuracy will be computed as the 
number of correct characters displayed divided by the total number of characters (14), 
multiplied by 100%.  
 
e.  Secondary Parameters 
The secondary parameters obtained will be used for the spelling test. 
1. Run P300_GUI in Matlab 2008. 
2. Select the 4 complete runs from the secondary calibration. 
3. Generate feature weights for the secondary calibration data. 
4. Save the *.mud and *.prm(v2) files. 
 
Method 2:  Ground and Reference Electrodes Directly Below the Ear 
This method is identical to method one except in the placement of the ground and reference 
electrodes.   
1. Remove the electrodes located on the mastoids from the electrode cap.   
2. Center the electrode corresponding to the left mastoid directly below the left ear and the 
electrode corresponding to the right mastoid directly below the right ear.  Secure with 
medical tape if necessary. 
3. Run the test sequence as specified previously for Initial Calibration and Initial 
Parameters.   
 
Method 3:  Ground and Reference Electrodes 5 cm Below the Ear 
This method is identical to method one except in the placement of the ground and reference 
electrodes.   
1. Remove the electrodes located on the mastoids from the electrode cap.   
2. Place the electrode corresponding to the left mastoid 5 cm below the left ear and the 
electrode corresponding to the right mastoid on 5 cm below the right ear.  Secure with 
medical tape if necessary.   
3. Run the test sequence as specified previously for Initial Calibration and Initial 
Parameters.   
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&ote: 
1. Current medications as well as diagnostic and demographic data will be tracked through 
an intake form approved by the Drexel University College of Medicine Institutional 
Review Board.    
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APPE&DIX D:  TEST SYSTEM RESULTS 
 
The test system was initially examined using a single electrode to prove that an AC signal could 
travel through the electrode and be read by a data acquisition program.   
 
 
Four electrodes may be examined by the DATAQ acquisition system at one time.  The AC signal 
obtained is consistent across each electrode and the electrodes are sensitive to changes in signal 
amplitude. 
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APPE&DIX E:  P300 SPELLI&G ACCURACY 
Subject M/F  Age Diag 
Date of 
Symptom 
Onset 
Date of 
Diagnosis 
ALSFRS 
Percent 
Correct 
Medications 
BCI004 M 55 ALS 12/8/2004 2/22/2005 18 93 
Rilutek 
L-Carnitine 
Neurontin 
Nexium 
Chlorazepate 
Vitamin B 
Baclofen 
Avapro 
Lyrica 
Tricor 
BCI006 M 54 ALS   1/1/1998 27 86 
Paxil 
Zyrtec 
Clonazepam 
Tylenol 
Antara  
Valium 
Zanaflex 
Neurodex 
BCI007 F 66 ALS 8/1/2004 4/1/2006 27 71 
Hyzaar 
Zoloft 150 
CoQ10 
Creatine 
Robinul 
Ativan 
Vitamin B 
BCI008 F 57 ALS 8/1/1995 9/23/1999 33 64 
Baclofen 
Tamoxifen 
Ditropan 
Tylenol 
Darvocet 
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BCI009 M 54 ALS 10/24/2007 1/1/2009 1 100 
Albuterol 
Acetylcysteine  
Lexapro 
Vitamin D 
Ursodiol 
Neurontin 
Miralex  
KCl  
Feosol, 
CoQ10 Ultram 
Indocin 
Omeprazole 
Dulcolax 
Ambien 
BCI011 F 48 ALS 8/1/2005 4/24/2007 34 100 Rilutek 
BCI012 M 50 ALS 3/1/2005 2/1/2006 1 79 
Rilutek  
Elavil  
Sudafed 
Ativan 
Tylenol 
Naprosyn 
Fentanyl 
Aspirin 
Nasonex 
Atrovent 
Duoneb 
Centrum 
Reglan 
Pulmicort 
Robitussin 
Novolog 
Insulin 
Lexapro 
Flexeril 
Zegerid 
BCI013 M 38 ALS   3/25/2005 11 100 
Klonopin 
Baclofen 
Zyrtec 
Scopalamine 
Guaifenecin 
Restaid 
Rilutek 
Arimoclomol 
Lithium 
BCI001 F 43 Control NA NA NA 100   
BCI002 M 24 Control NA NA NA 100   
BCI003 M 22 Control NA NA NA 86   
BCI014 M 23 Control NA NA NA 100   
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APPE&DIX F:  A&ALYSIS OF THE P300 WAVEFORM BY SUBJECT 
HEALTHY CO&TROLS 
BCI002 
 
 
BCI003 
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BCI014 
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APPE&DIX G:  PEAK VALUES BY SUBJECT A&D CHA&&EL 
P300 Speller 
Subject Disease Peak Amplitude Peak r^2 
BCI001 Control 
Ch 
Time 
(ms) 
Amp 
(mv) r^2 
Time 
(ms) 
Amp 
(mv) r^2 
1 207.0 2.611 0.010990 527.3 -2.388 0.011880 
2 203.1 2.573 0.015770 515.6 -2.737 0.020800 
3 312.5 2.189 0.001589 156.3 -3.855 0.015940 
4 750.0 1.479 0.000407 515.6 -1.220 0.012740 
5 101.6 1.387 0.000032 515.6 -0.846 0.010810 
6 308.6 2.957 0.008276 183.6 -5.036 0.068610 
7 316.4 2.028 0.003564 214.8 -2.511 0.027580 
8 312.5 2.479 0.005029 160.2 -3.763 0.022860 
BCI002 Control 
Ch Time Amp r^2 Time Amp r^2 
1 230.5 1.691 0.006792 304.7 -1.011 0.007507 
2 226.6 1.901 0.008096 289.1 -1.261 0.010600 
3 359.4 1.517 0.018620 367.2 1.462 0.019380 
4 230.5 1.584 0.002225 371.1 0.829 0.012490 
5 453.1 1.352 0.002304 375.0 0.951 0.018380 
6 328.1 2.036 0.010880 359.4 1.726 0.022250 
7 332.0 1.690 0.016110 371.1 0.830 0.023420 
8 328.1 2.242 0.016960 355.5 1.224 0.020160 
BCI003 Control 
Ch Time Amp r^2 Time Amp r^2 
1 230.5 1.404 0.001149 710.9 -1.853 0.004282 
2 230.5 2.353 0.007140 543.0 -1.723 0.007727 
3 226.6 1.502 0.004030 589.8 -1.659 0.005453 
4 230.5 2.113 0.007197 589.8 -1.994 0.008857 
5 226.6 1.906 0.007895 589.8 -1.567 0.008034 
6 97.7 1.031 0.002096 445.3 -0.942 0.003481 
7 230.5 1.225 0.002328 175.8 -1.280 0.006139 
8 97.7 1.099 0.003774 589.8 -1.123 0.004585 
BCI014 Control 
Ch Time Amp r^2 Time Amp r^2 
1 222.7 4.045 0.006108 554.7 -3.502 0.023370 
2 207.0 3.513 0.009257 558.6 -4.038 0.026110 
3 375.0 3.520 0.014470 390.6 3.336 0.018450 
4 375.0 3.713 0.012140 582.0 -4.418 0.017270 
5 375.0 3.798 0.024730 386.7 3.225 0.026410 
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6 375.0 4.098 0.021930 234.4 -5.267 0.048950 
7 277.3 4.060 0.005900 382.8 3.092 0.038470 
8 339.8 4.536 0.049730 339.8 4.536 0.049730 
BCI004 ALS 
Ch Time Amp r^2 Time Amp r^2 
1 226.6 5.016 0.016790 226.6 5.016 0.016790 
2 226.6 5.687 0.022150 226.6 5.687 0.022150 
3 203.1 3.044 0.009666 203.1 3.044 0.009666 
4 222.7 4.548 0.018830 222.7 4.548 0.018830 
5 226.6 1.874 0.009767 203.1 1.715 0.010880 
6 347.7 1.885 0.000882 58.6 0.369 0.001989 
7 343.8 2.333 0.002143 203.1 1.098 0.007837 
8 347.7 1.913 0.002353 203.1 1.666 0.008779 
BCI006 ALS 
Ch Time Amp r^2 Time Amp r^2 
1 210.9 2.569 0.005293 613.3 -3.236 0.015520 
2 210.9 2.669 0.005194 613.3 -2.314 0.009101 
3 761.7 2.018 0.000843 58.6 -1.495 0.002620 
4 554.7 1.911 0.000524 160.2 1.347 0.004955 
5 554.7 1.575 0.000301 523.4 -1.075 0.005617 
6 765.6 2.614 0.002264 656.3 0.765 0.002389 
7 550.8 1.880 0.001149 304.7 1.626 0.003010 
8 761.7 2.409 0.001174 175.8 0.772 0.002834 
BCI007 ALS 
Ch Time Amp r^2 Time Amp r^2 
1 199.2 4.747 0.011010 199.2 4.747 0.011010 
2 199.2 4.278 0.009493 199.2 4.278 0.009493 
3 199.2 2.749 0.003983 199.2 2.749 0.003983 
4 199.2 3.210 0.005728 199.2 3.210 0.005728 
5 199.2 2.525 0.003570 394.5 1.603 0.003687 
6 66.4 2.954 0.003970 62.5 2.843 0.003979 
7 293.0 2.244 0.003103 175.8 -2.643 0.005724 
8 293.0 2.830 0.004154 144.5 -2.437 0.006363 
BCI008 ALS 
Ch Time Amp r^2 Time Amp r^2 
1 191.4 1.252 0.002050 593.8 -1.521 0.003253 
2 195.3 1.462 0.005015 199.2 1.440 0.005169 
3 203.1 1.598 0.007460 203.1 1.598 0.007460 
4 199.2 1.527 0.006789 199.2 1.527 0.006789 
5 199.2 1.160 0.004909 632.8 -0.929 0.005035 
6 203.1 1.086 0.003903 203.1 1.086 0.003903 
7 320.3 1.201 0.002927 632.8 -0.795 0.003238 
8 324.2 1.169 0.001101 203.1 0.954 0.005341 
BCI009 ALS 
Ch Time Amp r^2 Time Amp r^2 
1 210.9 3.420 0.009678 230.5 2.781 0.010850 
 91 
2 214.8 4.052 0.025360 230.5 3.822 0.025710 
3 550.8 2.555 0.000478 308.6 -1.637 0.013320 
4 230.5 2.395 0.019300 183.6 1.727 0.020550 
5 152.3 1.932 0.005015 179.7 1.390 0.014330 
6 546.9 3.823 0.001279 308.6 0.341 0.006564 
7 550.8 2.152 0.004380 410.2 0.363 0.012990 
8 550.8 3.309 0.001942 304.7 0.112 0.003695 
BCI011 ALS 
Ch Time Amp r^2 Time Amp r^2 
1 210.9 4.368 0.011780 234.4 4.200 0.018220 
2 238.3 2.934 0.011590 238.3 2.934 0.011590 
3 308.6 3.487 0.006419 164.1 -5.983 0.018210 
4 539.1 3.378 0.000506 726.6 -0.008 0.004874 
5 543.0 2.842 0.000651 164.1 -4.260 0.004725 
6 335.9 3.851 0.006321 164.1 -5.636 0.022140 
7 339.8 2.462 0.001164 164.1 -3.940 0.015070 
8 335.9 3.135 0.008164 140.6 -3.793 0.022520 
BCI012 ALS 
Ch Time Amp r^2 Time Amp r^2 
1 222.7 2.748 0.005959 609.4 -2.807 0.008537 
2 218.8 4.225 0.012760 230.5 4.098 0.014290 
3 335.9 1.860 0.001197 593.8 -2.101 0.005780 
4 347.7 2.082 0.002124 593.8 -2.346 0.005111 
5 347.7 1.938 0.002380 593.8 -1.906 0.004276 
6 117.2 1.779 0.000401 414.1 0.527 0.002344 
7 351.6 1.814 0.001885 351.6 1.814 0.001885 
8 351.6 2.057 0.001252 418.0 0.214 0.002569 
BCI013 ALS 
Ch Time Amp r^2 Time Amp r^2 
1 152.3 4.673 0.002188 613.3 -3.446 0.002225 
2 156.3 5.225 0.002556 609.4 -4.145 0.002777 
3 152.3 3.182 0.001017 750.0 2.698 0.001729 
4 152.3 3.656 0.001539 750.0 2.836 0.002013 
5 750.0 2.908 0.002323 750.0 2.908 0.002323 
6 750.0 3.128 0.002095 750.0 3.128 0.002095 
7 750.0 2.546 0.001968 750.0 2.546 0.001968 
8 750.0 2.699 0.001933 750.0 2.699 0.001933 
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Optimization of Ground and Reference Electrode Placement 
Subject Loc Peak Amplitude Peak r^2 
BCI014 1 
Ch 
Time 
(ms) 
Amp 
(mv) r^2 
Time 
(ms) 
Amp 
(mv) r^2 
1 214.8 3.269 0.008760 585.9 -4.983 0.027840 
2 378.9 3.335 0.010870 585.9 -5.620 0.038170 
3 382.8 3.417 0.018910 644.5 -3.913 0.034030 
4 378.9 3.989 0.017310 585.9 -4.758 0.030740 
5 378.9 4.167 0.035160 386.7 3.676 0.038140 
6 382.8 4.210 0.034830 234.4 -4.478 0.042520 
7 382.8 4.760 0.056600 386.7 4.274 0.058870 
8 335.9 3.789 0.042810 339.8 3.543 0.044070 
BCI014 2 
Ch Time Amp r^2 Time Amp r^2 
1 375.0 2.179 0.003862 558.6 -1.999 0.005893 
2 371.1 3.504 0.010800 367.2 3.292 0.010810 
3 335.9 2.294 0.011330 429.7 1.714 0.015520 
4 335.9 3.042 0.016480 339.8 2.993 0.016940 
5 335.9 4.167 0.024780 339.8 3.995 0.025030 
6 339.8 3.331 0.016920 230.5 -6.549 0.050110 
7 335.9 4.856 0.031360 339.8 4.723 0.031990 
8 339.8 3.933 0.027460 339.8 3.933 0.027460 
BCI014 3 
Ch Time Amp r^2 Time Amp r^2 
1 218.8 2.992 0.002221 175.8 1.429 0.004638 
2 371.1 3.060 0.005121 335.9 1.856 0.005452 
3 332.0 3.025 0.009374 335.9 3.003 0.010320 
4 281.3 3.425 0.000827 335.9 3.135 0.010260 
5 281.3 4.890 0.003132 335.9 3.710 0.012720 
6 335.9 4.326 0.013540 339.8 4.160 0.014580 
7 281.3 6.111 0.006309 339.8 4.049 0.015780 
8 335.9 4.206 0.016450 339.8 4.139 0.017450 
BCI015 1 
Ch Time Amp r^2 Time Amp r^2 
1 410.2 2.875 0.007030 707.0 -3.637 0.027730 
2 418.0 1.924 0.004805 707.0 -2.216 0.020330 
3 156.3 1.140 0.002470 371.1 -2.177 0.009135 
4 226.6 1.921 0.005386 652.3 -1.533 0.010420 
5 234.4 2.178 0.010370 378.9 -2.612 0.019000 
6 148.4 0.720 0.001910 371.1 -2.531 0.020580 
7 238.3 0.996 0.003199 375.0 -2.040 0.029880 
8 242.2 1.283 0.002909 429.7 1.058 0.014950 
BCI015 2 
Ch Time Amp r^2 Time Amp r^2 
1 218.8 3.383 0.004589 636.7 -5.093 0.018200 
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2 222.7 3.337 0.004610 632.8 -3.847 0.011350 
3 230.5 2.415 0.003180 593.8 -2.491 0.004653 
4 230.5 3.198 0.004990 597.7 -2.902 0.005566 
5 234.4 3.434 0.005969 234.4 3.434 0.005969 
6 785.2 2.756 0.004794 785.2 2.756 0.004794 
7 785.2 2.150 0.003557 441.4 1.561 0.004698 
8 468.8 2.396 0.003053 441.4 1.736 0.004925 
BCI012 1 
Ch Time Amp r^2 Time Amp r^2 
1 214.8 3.991 0.005479 230.5 3.856 0.006180 
2 214.8 4.444 0.008628 214.8 4.444 0.008628 
3 347.7 2.356 0.003620 332.0 2.258 0.003936 
4 214.8 2.302 0.005477 214.8 2.302 0.005477 
5 332.0 2.015 0.003784 246.1 1.897 0.005460 
6 347.7 1.930 0.002108 414.1 0.610 0.002142 
7 332.0 1.997 0.002827 332.0 1.997 0.002827 
8 347.7 2.278 0.003013 347.7 2.278 0.003013 
BCI012 2 
Ch Time Amp r^2 Time Amp r^2 
1 218.8 2.634 0.004489 644.5 -1.173 0.004849 
2 214.8 3.631 0.006310 609.4 -3.064 0.009534 
3 351.6 2.170 0.001130 593.8 -2.229 0.004263 
4 351.6 1.968 0.001258 593.8 -2.508 0.005458 
5 347.7 2.026 0.000610 609.4 -1.967 0.003464 
6 351.6 2.063 0.000616 593.8 -1.360 0.002548 
7 347.7 2.039 0.000487 226.6 -2.406 0.003228 
8 347.7 2.314 0.000349 402.3 0.503 0.002108 
BCI012 3 
Ch Time Amp r^2 Time Amp r^2 
1 242.2 2.403 0.004629 484.4 -3.320 0.006742 
2 242.2 3.271 0.006826 585.9 -3.882 0.008604 
3 343.8 3.085 0.001700 585.9 -2.655 0.005079 
4 343.8 3.082 0.002076 585.9 -3.018 0.006414 
5 343.8 3.541 0.002643 585.9 -2.351 0.004354 
6 343.8 2.808 0.001054 585.9 -1.522 0.002545 
7 343.8 3.502 0.003204 218.8 -3.266 0.005010 
8 343.8 3.576 0.001872 375.0 1.445 0.003119 
BCI006 1 
Ch Time Amp r^2 Time Amp r^2 
1 210.9 2.174 0.004282 628.9 -2.839 0.018760 
2 210.9 2.369 0.005029 628.9 -1.807 0.011330 
3 113.3 1.733 0.000634 636.7 -1.211 0.004235 
4 175.8 1.702 0.005749 175.8 1.702 0.005749 
5 175.8 1.769 0.007764 175.8 1.769 0.007764 
6 113.3 1.883 0.000793 636.7 -1.118 0.003064 
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7 117.2 1.559 0.001193 128.9 1.154 0.003996 
8 546.9 1.921 0.000399 132.8 1.086 0.005376 
BCI006 2 
Ch Time Amp r^2 Time Amp r^2 
1 402.3 1.723 0.002028 664.1 -2.566 0.024790 
2 183.6 2.291 0.004982 668.0 -0.436 0.005944 
3 632.8 1.892 0.002855 503.9 1.245 0.009139 
4 632.8 1.839 0.002838 558.6 1.078 0.005402 
5 632.8 1.959 0.002083 503.9 0.622 0.005965 
6 632.8 2.553 0.007126 507.8 1.180 0.011100 
7 632.8 2.114 0.004221 503.9 0.938 0.008693 
8 632.8 2.113 0.004286 503.9 0.961 0.008769 
BCI006 3 
Ch Time Amp r^2 Time Amp r^2 
1 183.6 1.545 0.001161 609.4 -2.764 0.006185 
2 183.6 2.259 0.002133 609.4 -1.895 0.002999 
3 632.8 2.001 0.001390 582.0 1.656 0.003585 
4 183.6 1.889 0.001427 371.1 -1.131 0.003724 
5 632.8 2.016 0.000820 457.0 -2.047 0.002132 
6 632.8 2.765 0.003273 582.0 2.163 0.004943 
7 632.8 2.686 0.003005 582.0 1.982 0.004339 
8 632.8 2.686 0.003067 582.0 1.998 0.004440 
 
  
